Menu
Back to Journals » OncoTargets and Therapy » Volume 8 » default
OncoTargets and Therapy
ISSN: 1178-6930
- View all (6431)
- Volume 16, 2023 (140)
- Volume 15, 2022 (191)
- Volume 14, 2021 (525)
- Volume 13, 2020 (1171)
- Volume 12, 2019 (1075)
- Volume 11, 2018 (882)
- Volume 10, 2017 (615)
- Volume 9, 2016 (802)
- Volume 8, 2015 (439)
- Volume 7, 2014 (253)
- Volume 6, 2013 (208)
- Volume 5, 2012 (54)
- Volume 4, 2011 (19)
- Volume 3, 2010 (22)
- Volume 2, 2009 (25)
- Volume 1, 2008 (10)
Archive: Volume 8, 2015
MicroRNA-125a-5p regulates cancer cell proliferation and migration through NAIF1 in prostate carcinoma
Fu Y, Cao F
OncoTargets and Therapy 2015, 8:3827-3835
Published Date: 17 December 2015
Validation of a quantitative 12-multigene expression assay (Oncotype DX® Colon Cancer Assay) in Korean patients with stage II colon cancer: implication of ethnic differences contributing to differences in gene expression
Jeong DH, Kim WR, Min BS, Kim YW, Song MK, Kim NK
OncoTargets and Therapy 2015, 8:3817-3825
Published Date: 17 December 2015
Correlation of 18F-fluoroethyl tyrosine positron-emission tomography uptake values and histomorphological findings by stereotactic serial biopsy in newly diagnosed brain tumors using a refined software tool
Lopez WO, Cordeiro JG, Albicker U, Doostkam S, Nikkhah G, Kirch RD, Trippel M, Reithmeier T
OncoTargets and Therapy 2015, 8:3803-3815
Published Date: 17 December 2015
Prognostic and clinicopathological significance of serum interleukin-6 expression in colorectal cancer: a systematic review and meta-analysis
Wang Z, Wu P, Wu D, Zhang ZG, Hu GM, Zhao S, Lai YC, Huang J
OncoTargets and Therapy 2015, 8:3793-3801
Published Date: 16 December 2015
The role of CD44 in epithelial–mesenchymal transition and cancer development
Xu HX, Tian YJ, Yuan X, Wu H, Liu Q, Pestell RG, Wu KM
OncoTargets and Therapy 2015, 8:3783-3792
Published Date: 16 December 2015
Impact of age on the prognosis after liver transplantation for patients with hepatocellular carcinoma: a single-center experience
Wang P, Wang C, Li H, Shi B, Wang J, Zhong L
OncoTargets and Therapy 2015, 8:3775-3781
Published Date: 16 December 2015
Epidermal growth factor, latrophilin, and seven transmembrane domain-containing protein 1 marker, a novel angiogenesis marker
Serban F, Artene SA, Georgescu AM, Purcaru SO, Tache DE, Alexandru O, Dricu A
OncoTargets and Therapy 2015, 8:3767-3774
Published Date: 16 December 2015
Role of NSC319726 in ovarian cancer based on the bioinformatics analyses
Xue J, Yang G, Ding H, Wang P, Wang CH
OncoTargets and Therapy 2015, 8:3757-3765
Published Date: 15 December 2015
Prognostic impact of initial maximum standardized uptake value of 18F-FDG PET/CT on treatment response in patients with metastatic lung adenocarcinoma treated with erlotinib
Kus T, Aktas G, Sevinc A, Kalender ME, Yilmaz M, Kul S, Oztuzcu S, Oktay C, Camci C
OncoTargets and Therapy 2015, 8:3749-3756
Published Date: 15 December 2015
GIT1 is a novel prognostic biomarker and facilitates tumor progression via activating ERK/MMP9 signaling in hepatocellular carcinoma
Chen J, Yang P, Yang J, Wen Z, Zhang B, Zheng X
OncoTargets and Therapy 2015, 8:3731-3742
Published Date: 15 December 2015
NRBP1 is downregulated in breast cancer and NRBP1 overexpression inhibits cancer cell proliferation through Wnt/β-catenin signaling pathway
Wei H, Wang H, Ji Q, Sun J, Tao L, Zhou X
OncoTargets and Therapy 2015, 8:3721-3730
Published Date: 14 December 2015
Risks on N-acetyltransferase 2 and bladder cancer: a meta-analysis
Zhu Z, Zhang J, Jiang W, Zhang X, Li Y, Xu X
OncoTargets and Therapy 2015, 8:3715-3720
Published Date: 11 December 2015
Non-leukemic myeloid sarcoma involving the vulva, vagina, and cervix: a case report and literature review
Yu Y, Qin X, Yan S, Wang W, Sun Y, Zhang M
OncoTargets and Therapy 2015, 8:3707-3713
Published Date: 10 December 2015
Correlations between plasma endothelin-1 levels and breakthrough pain in patients with cancer
Yan XB, Peng TC, Huang D
OncoTargets and Therapy 2015, 8:3703-3706
Published Date: 8 December 2015
Profile of nintedanib in the treatment of solid tumors: the evidence to date
Awasthi N, Schwarz RE
OncoTargets and Therapy 2015, 8:3691-3701
Published Date: 8 December 2015
Association between MDM2 SNP309 T>G polymorphism and the risk of bladder cancer: new data in a Chinese population and an updated meta-analysis
Xie LG, Sun Y, Chen T, Tian DW, Li YJ, Zhang Y, Ding N, Shen ZH, Xu H, Nian XW, Sha N, Han RF, Hu HL, Wu CL
OncoTargets and Therapy 2015, 8:3679-3690
Published Date: 7 December 2015
Crosstalk with cancer-associated fibroblasts induces resistance of non-small cell lung cancer cells to epidermal growth factor receptor tyrosine kinase inhibition
Choe C, Shin YS, Kim C, Choi SJ, Lee J, Kim SY, Cho YB, Kim J
OncoTargets and Therapy 2015, 8:3665-3678
Published Date: 7 December 2015
Echinacoside induces apoptotic cancer cell death by inhibiting the nucleotide pool sanitizing enzyme MTH1
Dong L, Wang H, Niu J, Zou M, Wu N, Yu D, Wang Y, Zou Z
OncoTargets and Therapy 2015, 8:3649-3664
Published Date: 8 December 2015
Downregulation of microRNA-132 by DNA hypermethylation is associated with cell invasion in colorectal cancer
Qin J, Ke J, Xu JF, Wang FR, Zhou YL, Jiang YS, Wang ZW
OncoTargets and Therapy 2015, 8:3639-3648
Published Date: 7 December 2015
Potential role for mammalian target of rapamycin inhibitors as first-line therapy in hormone receptor–positive advanced breast cancer
Beck JT
OncoTargets and Therapy 2015, 8:3629-3638
Published Date: 7 December 2015
Long-term administration of high doses of transdermal buprenorphine in cancer patients with severe neuropathic pain
Leppert W, Kowalski G
OncoTargets and Therapy 2015, 8:3621-3627
Published Date: 4 December 2015
First-line chemotherapy in patients with metastatic gastroenteropancreatic neuroendocrine carcinoma
Bongiovanni A, Riva N, Ricci M, Liverani C, La Manna F, De Vita A, Foca F, Mercatali L, Severi S, Amadori D, Ibrahim T
OncoTargets and Therapy 2015, 8:3613-3619
Published Date: 3 December 2015
Restoration of BRG1 inhibits proliferation and metastasis of lung cancer by regulating tumor suppressor miR-148b
Zhou Z, Su Y, Fa X
OncoTargets and Therapy 2015, 8:3603-3612
Published Date: 2 December 2015
Prognostic value of programmed cell death-ligand 1 expression in patients with non-small-cell lung cancer: evidence from an updated meta-analysis
Zhong AY, Xing YF, Pan X, Shi MH, Xu HJ
OncoTargets and Therapy 2015, 8:3595-3601
Published Date: 1 December 2015
Inhibitive effects of 15-deoxy-Δ12,14-prostaglandin J2 on hepatoma-cell proliferation through reactive oxygen species-mediated apoptosis
Chen K, Dai W, Wang F, Xia Y, Li J, Li S, Liu T, Zhang R, Wang J, Lu W, Zhou Y, Yin Q, Zheng Y, Abudumijiti H, Chen R, Lu J, Zhou Y, Guo C
OncoTargets and Therapy 2015, 8:3585-3593
Published Date: 1 December 2015
The relationship between UGT1A1 gene polymorphism and irinotecan effect on extensive-stage small-cell lung cancer
Xiao XG, Xia S, Zou M, Mei Q, Zhou L, Wang SJ, Chen Y
OncoTargets and Therapy 2015, 8:3575-3583
Published Date: 3 December 2015
Inhibition of FOXO1 by small interfering RNA enhances proliferation and inhibits apoptosis of papillary thyroid carcinoma cells via Akt/FOXO1/Bim pathway
Song HM, Song JL, Li DF, Hua KY, Zhao BK, Fang L
OncoTargets and Therapy 2015, 8:3565-3573
Published Date: 1 December 2015
A metastatic colon adenocarcinoma harboring BRAF V600E has a durable major response to dabrafenib/trametinib and chemotherapy
Williams CB, McMahon C, Ali SM, Abramovitz M, Williams KA, Klein J, McKean H, Yelensky R, George Jr TJ, Elvin JA, Soman S, Lipson D, Chmielecki J, Morosini D, Miller VA, Stephens PJ, Ross JS, Leyland-Jones B
OncoTargets and Therapy 2015, 8:3561-3564
Published Date: 1 December 2015
Inhibition of TGF-β signaling with halofuginone can enhance the antitumor effect of irradiation in Lewis lung cancer
Lin RL, Yi S, Gong LL, Liu WS, Wang P, Liu NB, Zhao LJ, Wang P
OncoTargets and Therapy 2015, 8:3549-3559
Published Date: 2 December 2015
Ultrasound-guided RNA interference targeting HIF-1 alpha improves the effects of transarterial chemoembolization in rat liver tumors
Chen CS, Zhao Q, Qian S, Li HL, Guo CY, Zhang W, Yan ZP, Liu R, Wang JH
OncoTargets and Therapy 2015, 8:3539-3548
Published Date: 27 November 2015
The XRCC1 Arg194Trp polymorphism is significantly associated with lung adenocarcinoma: a case-control study in an Eastern European Caucasian group
Cătană A, Pop M, Hincu BD, Pop IV, Petrişor FM, Porojan MD, Popp RA
OncoTargets and Therapy 2015, 8:3533-3538
Published Date: 27 November 2015
Relationship between high-mobility group box 1 overexpression in ovarian cancer tissue and serum: a meta-analysis
Wang HP, Li ZJ, Sun YL, Xu ZF, Han JJ, Song B, Song WT, Qin C, Yin L
OncoTargets and Therapy 2015, 8:3523-3531
Published Date: 27 November 2015
The association between osteopontin and survival in non-small-cell lung cancer patients: a meta-analysis of 13 cohorts
Wang Y, Yang J, Liu H, Bi JR, Liu Y, Chen YY, Cao JY, Lu YJ
OncoTargets and Therapy 2015, 8:3513-3521
Published Date: 26 November 2015
Ability of PITX2 methylation to predict survival in patients with prostate cancer
Li JZ, Zhang Y, Wen B, Li M, Wang YJ
OncoTargets and Therapy 2015, 8:3507-3512
Published Date: 24 November 2015
Expression of CPEB4 in invasive ductal breast carcinoma and its prognostic significance
Sun HT, Wen X, Han T, Liu ZH, Li SB, Wang JG, Liu XP
OncoTargets and Therapy 2015, 8:3499-3506
Published Date: 26 November 2015
Effect of gyromagnetic fields on human prostatic adenocarcinoma cells
Lei H, Xu Y, Guan R, Li M, Hui Y, Gao Z, Yang B, Xin Z
OncoTargets and Therapy 2015, 8:3489-3497
Published Date: 24 November 2015
Polo-like kinase 2 acting as a promoter in human tumor cells with an abundance of TAp73
Hu ZB, Xu ZY, Liao XH, Yang X, Dong C, Luk K, Jin AM, Lu H
OncoTargets and Therapy 2015, 8:3475-3488
Published Date: 20 November 2015
Knockdown of a HIF-2α promoter upstream long noncoding RNA impairs colorectal cancer stem cell properties in vitro through HIF-2α downregulation
Yao J, Li J, Geng P, Li Y, Chen H, Zhu Y
OncoTargets and Therapy 2015, 8:3467-3474
Published Date: 25 November 2015
Comparative study on individual aromatase inhibitors on cardiovascular safety profile: misleading analysis and doubtful methodology
Guo WQ, Li L
OncoTargets and Therapy 2015, 8:3465-3466
Published Date: 20 November 2015
Yttrium-90 radioembolization for advanced inoperable hepatocellular carcinoma
Lee VHF, Leung DKC, Luk MY, Tong CC, Law MWM, Ng SCY, Wong KK, Poon RTP, Kwong DLW, Leung TW
OncoTargets and Therapy 2015, 8:3457-3464
Published Date: 20 November 2015
High DEPTOR expression correlates with poor prognosis in patients with esophageal squamous cell carcinoma
Liu NB, Zhang JH, Liu YF, Li J, Zhang ZZ, Li JW, Liu WY, Huang C, Shen T, Gu CW, Gao DY, Wu X, Wu X
OncoTargets and Therapy 2015, 8:3449-3455
Published Date: 19 November 2015
Differences in clinical features between laparoscopy and open resection for primary tumor in patients with stage IV colorectal cancer
Kim IY, Kim BR, Kim HS, Kim YW
OncoTargets and Therapy 2015, 8:3441-3448
Published Date: 19 November 2015
Diagnostic value of SHOX2 DNA methylation in lung cancer: a meta-analysis
Zhao QT, Guo T, Wang HE, Zhang XP, Zhang H, Wang ZK, Yuan Z, Duan GC
OncoTargets and Therapy 2015, 8:3433-3439
Published Date: 19 November 2015
Profile of bevacizumab and its potential in the treatment of cervical cancer
Fisher CM, Schefter TE
OncoTargets and Therapy 2015, 8:3425-3431
Published Date: 19 November 2015
Baseline blood immunological profiling differentiates between Her2– breast cancer molecular subtypes: implications for immunomediated mechanisms of treatment response
Tudoran O, Virtic O, Balacescu L, Lisencu C, Fetica B, Gherman C, Balacescu O, Berindan-Neagoe I
OncoTargets and Therapy 2015, 8:3415-3423
Published Date: 18 November 2015
Novel prognostic genes of diffuse large B-cell lymphoma revealed by survival analysis of gene expression data
Li CL, Zhu B, Chen J, Huang XB
OncoTargets and Therapy 2015, 8:3407-3413
Published Date: 18 November 2015
Impact of lymphovascular invasion on recurrence and progression rates in patients with pT1 urothelial carcinoma of bladder after transurethral resection
Sha N, Xie L, Chen T, Xing C, Liu X, Zhang Y, Shen Z, Xu H, Wu Z, Hu H, Wu C
OncoTargets and Therapy 2015, 8:3401-3406
Published Date: 18 November 2015
Overexpression of miR-100 inhibits cell proliferation, migration, and chemosensitivity in human glioblastoma through FGFR3
Luan YX, Zhang SY, Zuo L, Zhou LX
OncoTargets and Therapy 2015, 8:3391-3400
Published Date: 17 November 2015
Experience with combination of nimotuzumab and intensity-modulated radiotherapy in patients with locoregionally advanced nasopharyngeal carcinoma
Zhai RP, Ying HM, Kong FF, Du CR, Huang S, Zhou JJ, Hu CS
OncoTargets and Therapy 2015, 8:3383-3390
Published Date: 18 November 2015
Dynamin-related protein 1 is involved in micheliolide-induced breast cancer cell death
Jia Y, Zhou L, Tian C, Shi Y, Wang C, Tong Z
OncoTargets and Therapy 2015, 8:3371-3381
Published Date: 16 November 2015
Prognostic value of Bcl-2 expression in patients with non-small-cell lung cancer: a meta-analysis and systemic review
Zhang J, Wang SF, Wang L, Wang R, Chen SF, Pan B, Sun YH, Chen HQ
OncoTargets and Therapy 2015, 8:3361-3369
Published Date: 18 November 2015
Utility of gonadotropin-releasing hormone agonists for prevention of chemotherapy-induced ovarian damage in premenopausal women with breast cancer: a systematic review and meta-analysis
Shen YW, Zhang XM, Lv M, Chen L, Qin TJ, Wang F, Yang J, Liu PJ, Yang J
OncoTargets and Therapy 2015, 8:3349-3359
Published Date: 13 November 2015
Hormone receptor status predicts the clinical outcome of human epidermal growth factor 2-positive metastatic breast cancer patients receiving trastuzumab therapy: a multicenter retrospective study
Wang YC, Sun T, Wan DG, Sheng LJ, Li W, Zhu HY, Li YP, Lu J
OncoTargets and Therapy 2015, 8:3337-3348
Published Date: 11 November 2015
Cetuximab could be more effective without prior bevacizumab treatment in metastatic colorectal cancer patients
Sato Y, Matsusaka S, Suenaga M, Shinozaki E, Mizunuma N
OncoTargets and Therapy 2015, 8:3329-3336
Published Date: 11 November 2015
Incidence and clinical significance of ESR1 mutations in heavily pretreated metastatic breast cancer patients
Niu J, Andres G, Kramer K, Kundranda MN, Alvarez RH, Klimant E, Parikh AR, Tan B, Staren ED, Markman M
OncoTargets and Therapy 2015, 8:3323-3328
Published Date: 11 November 2015
Concurrent radiotherapy with oral fluoropyrimidine versus gemcitabine in locally advanced pancreatic cancer: a systematic review and meta-analysis
Yang YF, Cao XH, Bao CE, Wan X
OncoTargets and Therapy 2015, 8:3315-3322
Published Date: 9 November 2015
O-GlcNAcylation enhances the invasion of thyroid anaplastic cancer cells partially by PI3K/Akt1 pathway
Zhang P, Wang CL, Ma T, You SY
OncoTargets and Therapy 2015, 8:3305-3313
Published Date: 9 November 2015
Consolidation therapy of arsenic trioxide alternated with chemotherapy achieves remarkable efficacy in newly diagnosed acute promyelocytic leukemia
Liu CC, Wang H, Wang WD, Zhu MY, Geng QR, Lu Y
OncoTargets and Therapy 2015, 8:3297-3303
Published Date: 12 November 2015
Detection of epidermal growth factor receptor mutation in plasma as a biomarker in Chinese patients with early-stage non-small cell lung cancer
Guo K, Zhang ZP, Han L, Han J, Wang J, Zhou YA, Liu HG, Tong LP, Li XF, Yan XL
OncoTargets and Therapy 2015, 8:3289-3296
Published Date: 6 November 2015
The association between XRCC1 Arg399Gln polymorphism and risk of leukemia in different populations: a meta-analysis of case-control studies
Wang F, Zhao Q, He HR, Zhai YJ, Lu J, Hu HB, Zhou JS, Yang YH, Li YJ
OncoTargets and Therapy 2015, 8:3277-3287
Published Date: 6 November 2015
Assessing the potential value of long interspersed element-1 hypomethylation in colorectal cancer: evidence from retrospective studies
Tang JT, Wang ZH, Fang JY
OncoTargets and Therapy 2015, 8:3265-3276
Published Date: 5 November 2015
Use of taxane-containing induction chemotherapy in combination with concurrent chemoradiotherapy in Chinese patients with locally advanced nasopharyngeal carcinoma: a meta-analysis
Tian R, Ye HX, Zhang BG, Gu DY, Zhang BW, Teng ZP, Jin MY, Chen JF, Qi JW
OncoTargets and Therapy 2015, 8:3255-3263
Published Date: 5 November 2015
miR-21 inhibits the effects of cyclooxygenase-2 inhibitor NS398 on apoptosis and invasion in gastric cancer cells
Li HQ, Cheng J, Mao YQ, Jiang M, Fan XM
OncoTargets and Therapy 2015, 8:3245-3253
Published Date: 4 November 2015
Management experiences of primary angiosarcoma of breast: a retrospective study from single institute in the People’s Republic of China
Hu QC, Mei X, Feng Y, Ma JL, Yang ZZ, Shao ZM, Yu XL, Guo XM
OncoTargets and Therapy 2015, 8:3237-3243
Published Date: 4 November 2015
Percutaneous CT-guided microwave ablation as maintenance after first-line treatment for patients with advanced NSCLC
Ni X, Han JQ, Ye X, Wei ZG
OncoTargets and Therapy 2015, 8:3227-3235
Published Date: 3 November 2015
Implication of lncRNAs in pathogenesis of esophageal cancer
Tang WW, Wu QQ, Li SQ, Tong YS, Liu ZH, Yang TX, Xu Y, Cao XF
OncoTargets and Therapy 2015, 8:3219-3226
Published Date: 3 November 2015
miR-132 can inhibit glioma cells invasion and migration by target MMP16 in vitro
Wang HZ, Li XT, Wu C, Wu ZW, Li YY, Yang TQ, Chen GL, Xie XS, Huang YL, Du ZW, Zhou YX
OncoTargets and Therapy 2015, 8:3211-3218
Published Date: 3 November 2015
Correlation of C-X-C chemokine receptor 2 upregulation with poor prognosis and recurrence in human glioma
Yang L, Liu Z, Wu R, Yao Q, Gu Z, Liu M
OncoTargets and Therapy 2015, 8:3203-3209
Published Date: 2 November 2015
Impact of more detailed categorization of shrinkage or progression ratio at initial imaging response after sorafenib treatment in advanced hepatocellular carcinoma patients
Wada Y, Takami Y, Tateishi M, Ryu T, Mikagi K, Saitsu H
OncoTargets and Therapy 2015, 8:3193-3202
Published Date: 2 November 2015
Combination of cetuximab and PP242 synergistically suppress the progression of wild-type KRAS colorectal carcinoma
Cheng L, Xia Z, Bian X, Li G, Hu J, Cao Y, Wang Q, Qian X
OncoTargets and Therapy 2015, 8:3185-3192
Published Date: 2 November 2015
miR-122 inhibits metastasis and epithelial–mesenchymal transition of non-small-cell lung cancer cells
Qin HF, Sha JP, Jiang CX, Gao XM, Qu LL, Yan HY, Xu TJ, Jiang QY, Gao HJ
OncoTargets and Therapy 2015, 8:3175-3184
Published Date: 29 October 2015
Treating patients with advanced rectal cancer and lateral pelvic lymph nodes with preoperative chemoradiotherapy based on pretreatment imaging
Otowa Y, Yamashita K, Kanemitsu K, Sumi Y, Yamamoto M, Kanaji S, Imanishi T, Nakamura T, Suzuki S, Tanaka K, Kakeji Y
OncoTargets and Therapy 2015, 8:3169-3173
Published Date: 29 October 2015
MicroRNA-328 enhances cellular motility through posttranscriptional regulation of PTPRJ in human hepatocellular carcinoma
Luo X, Yang S, Zhou C, Pan F, Li Q, Ma S
OncoTargets and Therapy 2015, 8:3159-3167
Published Date: 28 October 2015
Perineural invasion correlates with postoperative distant metastasis and poor overall survival in patients with PT1–3N0M0 esophageal squamous cell carcinoma
Sheng L, Ji Y, Du X
OncoTargets and Therapy 2015, 8:3153-3157
Published Date: 27 October 2015
Expression and prognostic value of GalNAc-T3 in patients with completely resected small (≤2 cm) peripheral lung adenocarcinoma after IASLC/ATS/ERS classification
Zhao SL, Guo T, Li JX, Uramoto H, Guan HW, Deng WG, Gu CD
OncoTargets and Therapy 2015, 8:3143-3152
Published Date: 27 October 2015
A high LDL-C to HDL-C ratio predicts poor prognosis for initially metastatic colorectal cancer patients with elevations in LDL-C
Liao F, He W, Jiang C, Yin C, Guo G, Chen X, Qiu H, Rong Y, Zhang B, Xu D, Xia L
OncoTargets and Therapy 2015, 8:3135-3142
Published Date: 27 October 2015
SKF95365 induces apoptosis and cell-cycle arrest by disturbing oncogenic Ca2+ signaling in nasopharyngeal carcinoma cells
Zhang J, Wei J, He Q, Lin Y, Liang R, Ye J, Zhang Z, Li Y
OncoTargets and Therapy 2015, 8:3123-3133
Published Date: 27 October 2015
Serum dickkopf-1 as a biomarker in screening gastrointestinal cancers: a systematic review and meta-analysis
Liang B, Zhong L, He Q, Wang S, Pan Z, Wang T, Zhao Y
OncoTargets and Therapy 2015, 8:3115-3122
Published Date: 22 October 2015
Prognostic value of Notch-1 expression in hepatocellular carcinoma: a meta-analysis
Wu T, Jiao M, Jing L, Wang MC, Sun HF, Li Q, Bai YY, Wei YC, Nan KJ, Guo H
OncoTargets and Therapy 2015, 8:3105-3114
Published Date: 22 October 2015
Potential therapeutic strategy for gastric cancer peritoneal metastasis by NKG2D ligands-specific T cells
Liu XQ, Sun ML, Yu S, Liu K, Li XR, Shi H
OncoTargets and Therapy 2015, 8:3095-3104
Published Date: 22 October 2015
Concurrent chemoradiotherapy using paclitaxel plus cisplatin in the treatment of elderly patients with esophageal cancer
Song T, Zhang X, Fang M, Wu S
OncoTargets and Therapy 2015, 8:3087-3094
Published Date: 22 October 2015
Transarterial oily chemoembolization with lidamycin shows potent therapeutic efficacy in VX2 rabbit liver tumor
Zhong G, Qi J, Huo S, Xue H, Xu Z, Li J, Zhou Y, Wu M, Li L
OncoTargets and Therapy 2015, 8:3079-3086
Published Date: 22 October 2015
A DNA vaccine encoding mutated HPV58 mE6E7-Fc-GPI fusion antigen and GM-CSF and B7.1
Wang H, Yu J, Li L
OncoTargets and Therapy 2015, 8:3067-3077
Published Date: 23 October 2015
Combined olaparib and oxaliplatin inhibits tumor proliferation and induces G2/M arrest and γ-H2AX foci formation in colorectal cancer
Xu K, Chen Z, Cui Y, Qin C, He Y, Song X
OncoTargets and Therapy 2015, 8:3047-3054
Published Date: 20 October 2015
rs712 polymorphism within let-7 microRNA-binding site might be involved in the initiation and progression of colorectal cancer in Chinese population
Jiang QH, Peng HX, Zhang Y, Tian P, Xi ZL, Chen H
OncoTargets and Therapy 2015, 8:3041-3045
Published Date: 22 October 2015
Forkhead box protein A1 is a prognostic predictor and promotes tumor growth of gastric cancer
Ren H, Zhang P, Tang Y, Wu M, Zhang W
OncoTargets and Therapy 2015, 8:3029-3039
Published Date: 20 October 2015
miR-195 is a key regulator of Raf1 in thyroid cancer
Wang F, Jiang C, Sun Q, Yan F, Wang L, Fu Z, Liu T, Hu F
OncoTargets and Therapy 2015, 8:3021-3028
Published Date: 20 October 2015
EGFR gene-mutation status correlated with therapeutic decision making in lung adenocarcinoma
Ren YY, Yao YB, Ma Q, Zhong DS
OncoTargets and Therapy 2015, 8:3017-3020
Published Date: 20 October 2015
SOX2 expression is associated with FGFR fusion genes and predicts favorable outcome in lung squamous cell carcinomas
Zheng S, Pan Y, Wang R, Li Y, Cheng C, Shen X, Li B, Zheng D, Sun Y, Chen H
OncoTargets and Therapy 2015, 8:3009-3016
Published Date: 19 October 2015
Association between pre-miR-27a functional polymorphism and risk of colorectal cancer in north Chinese Han population
Bian Q, Chen JJ, Gu JP, Xu J
OncoTargets and Therapy 2015, 8:3003-3007
Published Date: 19 October 2015
Luteolin decreases invasiveness, deactivates STAT3 signaling, and reverses interleukin-6 induced epithelial–mesenchymal transition and matrix metalloproteinase secretion of pancreatic cancer cells
Huang XC, Dai SJ, Dai JJ, Xiao YW, Bai YY, Chen BC, Zhou MT
OncoTargets and Therapy 2015, 8:2989-3001
Published Date: 19 October 2015
MicroRNA-766 targeting regulation of SOX6 expression promoted cell proliferation of human colorectal cancer
Li YC, Li CF, Chen LB, Li DD, Yang L, Jin JP, Zhang B
OncoTargets and Therapy 2015, 8:2981-2988
Published Date: 20 October 2015
Links between cancer stem cells and epithelial– mesenchymal transition
Wang SS, Jiang J, Liang XH, Tang YL
OncoTargets and Therapy 2015, 8:2973-2980
Published Date: 16 October 2015
Mutation analysis underlying the downregulation of the thyroid hormone receptor β1 gene in the Chinese breast cancer population
Ling YQ, Ling XL, Fan L, Wang Y, Li Q
OncoTargets and Therapy 2015, 8:2967-2972
Published Date: 16 October 2015
Differential regulation of human Eag1 channel expression by serum and epidermal growth factor in lung and breast cancer cells
Acuña-Macías I, Vera E, Vázquez-Sánchez AY, Mendoza-Garrido ME, Camacho J
OncoTargets and Therapy 2015, 8:2959-2965
Published Date: 16 October 2015
Molecular profiling in the treatment of colorectal cancer: focus on regorafenib
Yan Y, Grothey A
OncoTargets and Therapy 2015, 8:2949-2957
Published Date: 15 October 2015
Incidence and clinical characteristics of unexpected uterine sarcoma after hysterectomy and myomectomy for uterine fibroids: a retrospective study of 10,248 cases
Zhao WC, Bi FF, Li D, Yang Q
OncoTargets and Therapy 2015, 8:2943-2948
Published Date: 15 October 2015
A human leucyl-tRNA synthetase as an anticancer target
Gao G, Yao Y, Li K, Mashausi DS, Li D, Negi H, Kamle S, Chen H, Wu Z, Zhou H, Li D
OncoTargets and Therapy 2015, 8:2933-2942
Published Date: 15 October 2015
Deregulation of secreted frizzled-related proteins is associated with aberrant β-catenin activation in the carcinogenesis of oral submucous fibrosis
Zhou S, Chen L, Mashrah M, Zhu Y, Liu J, Yang X, He Z, Wang L, Xiang T, Yao Z, Guo F, Yang W, Zhang C
OncoTargets and Therapy 2015, 8:2923-2931
Published Date: 14 October 2015
EGFR-TKIs in adjuvant treatment of lung cancer: to give or not to give?
Milovancev A, Stojsic V, Zaric B, Kovacevic T, Sarcev T, Perin B, Zarogoulidis K, Tsirgogianni K, Freitag L, Darwiche K, Tsavlis D, Zissimopoulos A, Stratakos G, Zarogoulidis P
OncoTargets and Therapy 2015, 8:2915-2921
Published Date: 13 October 2015
The functional role of microRNA in acute lymphoblastic leukemia: relevance for diagnosis, differential diagnosis, prognosis, and therapy
Luan CX, Yang ZX, Chen B
OncoTargets and Therapy 2015, 8:2903-2914
Published Date: 13 October 2015
Genetic polymorphisms of CYP1A1 and risk of leukemia: a meta-analysis
Lu J, Zhao Q, Zhai YJ, He HR, Yang LH, Gao F, Zhou RS, Zheng J, Ma XC
OncoTargets and Therapy 2015, 8:2883-2902
Published Date: 12 October 2015
The association of GSTT1 deletion polymorphism with lung cancer risk among Chinese population: evidence based on a cumulative meta-analysis
Wang Y, Yang H, Wang H
OncoTargets and Therapy 2015, 8:2875-2882
Published Date: 12 October 2015
Study of internal mammary sentinel lymph node biopsy in breast cancer patients after neoadjuvant chemotherapy
Cao XS, Cong BB, Sun X, Qiu PF, Wang YS
OncoTargets and Therapy 2015, 8:2873-2874
Published Date: 9 October 2015
Changing attitudes toward needle biopsies of breast cancer in Shanghai: experience and current status over the past 8 years
Hao S, Liu ZB, Ling H, Chen JJ, Shen JP, Yang WT, Shao ZM
OncoTargets and Therapy 2015, 8:2865-2871
Published Date: 9 October 2015
Role of estrogen in lung cancer based on the estrogen receptor-epithelial mesenchymal transduction signaling pathways
Zhao XZ, Liu Y, Zhou LJ, Wang ZQ, Wu ZH, Yang XY
OncoTargets and Therapy 2015, 8:2849-2863
Published Date: 9 October 2015
Postoperative intensity-modulated radiation therapy provides favorable local control and low toxicities in patients with soft tissue sarcomas in the extremities and trunk wall
Wang JY, Wang SL, Song YW, Liu XF, Jin J, Wang WH, Yu ZH, Liu YP, Li YX
OncoTargets and Therapy 2015, 8:2843-2847
Published Date: 9 October 2015
CXCL12 genetic variants as prognostic markers in nasopharyngeal carcinoma
Chen RW, Xu YF, Du XJ, Liu N, Li YQ, He QM, Tang LL, Mao YP, Sun Y, Chen L, Ma J
OncoTargets and Therapy 2015, 8:2835-2842
Published Date: 8 October 2015
Upregulated matrix metalloproteinase-2 and downregulated tissue factor pathway inhibitor-2 are risk factors for lymph node metastasis and perineural invasion in pancreatic carcinoma
Zhai LL, Wu Y, Cai CY, Tang ZG
OncoTargets and Therapy 2015, 8:2827-2834
Published Date: 7 October 2015
Does night-shift work increase the risk of prostate cancer? a systematic review and meta-analysis
Rao D, Yu H, Bai Y, Zheng X, Xie L
OncoTargets and Therapy 2015, 8:2817-2826
Published Date: 5 October 2015
Molecular diagnostics of a single drug-resistant multiple myeloma case using targeted next-generation sequencing
Ikeda H, Ishiguro K, Igarashi T, Aoki Y, Hayashi T, Ishida T, Sasaki Y, Tokino T, Shinomura Y
OncoTargets and Therapy 2015, 8:2805-2815
Published Date: 5 October 2015
Association between the COMT Val158Met polymorphism and risk of cancer: evidence from 99 case–control studies
Zhou Q, Wang Y, Chen AH, Tao YL, Song HM, Li W, Tao J, Zuo MZ
OncoTargets and Therapy 2015, 8:2791-2803
Published Date: 5 October 2015
Spotlight on decitabine for myelodysplastic syndromes in Chinese patients
Jing Y, Shen X, Mei Q, Han W
OncoTargets and Therapy 2015, 8:2783-2790
Published Date: 3 October 2015
Angiogenesis inhibitors rechallenge in patients with advanced non-small-cell lung cancer: a pooled analysis of randomized controlled trials
Zhao LD, Li W, Zhang HY, Hou N, Guo LW, Gao QL
OncoTargets and Therapy 2015, 8:2775-2781
Published Date: 3 October 2015
ESHAP chemotherapy is efficient in refractory/relapsed primary central nervous system lymphoma: report of four cases
Ungur R, Tempescul A, Berthou C, Bagacean C, Radeanu D, Muresan A, Zdrenghea M
OncoTargets and Therapy 2015, 8:2771-2773
Published Date: 1 October 2015
Sustained response of malignant pericardial effusion to intrapericardial bevacizumab in an advanced lung cancer patient: a case report and literature review
Chen DW, Zhang Y, Shi F, Li MH, Zhu H, Kong L, Yu JM
OncoTargets and Therapy 2015, 8:2767-2770
Published Date: 1 October 2015
Increased risk of developing lung cancer in Asian patients carrying the TERT rs2736098 G>A polymorphism: evidence from 3,354 cases and 3,518 controls
Yang ZH, Zhang XL, Fang SR, Tan Y, Yan HJ, Gu W, Wang JH
OncoTargets and Therapy 2015, 8:2757-2765
Published Date: 30 September 2015
Anti-DR5 mAb inhibits proliferation of human fibroblast-like synovial cells and reduces their cytokine secretion in vitro
Zhang M, Shi C, Xia C, Yang J, Niu X, Zhuang G, Yin P
OncoTargets and Therapy 2015, 8:2745-2755
Published Date: 29 September 2015
Advanced lung adenocarcinoma with spinal cord metastasis successfully treated with second EGFR-TKI treatment: a case report and literature review
Li X, Yang H, Zhao J, Gao H
OncoTargets and Therapy 2015, 8:2739-2743
Published Date: 29 September 2015
Prognostic role of neutrophil to lymphocyte ratio in lung cancers: a meta-analysis including 7,054 patients
Zhao QT, Yang Y, Xu S, Zhang XP, Wang HE, Zhang H, Wang ZK, Yuan Z, Duan GC
OncoTargets and Therapy 2015, 8:2731-2738
Published Date: 29 September 2015
Comparative study on individual aromatase inhibitors on cardiovascular safety profile: a network meta-analysis
Zhao XH, Liu L, Li K, Li WS, Zhao L, Zou HW
OncoTargets and Therapy 2015, 8:2721-2730
Published Date: 29 September 2015
The predictive effect of overexpressed miR-34a on good survival of cancer patients: a systematic review and meta-analysis
Wang J, Dan GR, Zhao JQ, Ding Y, Ye F, Sun HQ, Jiang F, Cheng J, Yuan FH, Zou ZM
OncoTargets and Therapy 2015, 8:2709-2719
Published Date: 25 September 2015
Validation study of the modified injection technique for internal mammary sentinel lymph node biopsy in breast cancer
Cong BB, Cao XS, Qiu PF, Liu YB, Zhao T, Chen P, Wang CJ, Zhang ZP, Sun X, Wang YS
OncoTargets and Therapy 2015, 8:2705-2708
Published Date: 24 September 2015
A study on the effect of IL-6 gene polymorphism on the prognosis of non-small-cell lung cancer
Jia W, Fei GH, Hu JG, Hu XW
OncoTargets and Therapy 2015, 8:2699-2704
Published Date: 23 September 2015
miR-98 targets ITGB3 to inhibit proliferation, migration, and invasion of non-small-cell lung cancer
Ni R, Huang Y, Wang J
OncoTargets and Therapy 2015, 8:2689-2697
Published Date: 22 September 2015
Bioinformatics analyses of differentially expressed genes associated with bisphosphonate-related osteonecrosis of the jaw in patients with multiple myeloma
Sun J, Wen X, Jin F, Li Y, Hu J, Sun Y
OncoTargets and Therapy 2015, 8:2681-2688
Published Date: 22 September 2015
Associations of polymorphisms in NAT2 gene with risk and metastasis of osteosarcoma in young Chinese population
Huang Z, Yuan L, Jiang Z, Wang D
OncoTargets and Therapy 2015, 8:2675-2680
Published Date: 22 September 2015
Clinical significance of locoregional and systemic treatment in operable high-risk breast cancer patients with more than four positive axillary lymph nodes
Yin K, Zhou L, Shao Z, Yin W, Lu J
OncoTargets and Therapy 2015, 8:2665-2673
Published Date: 21 September 2015
Long noncoding RNA CCAT2 promotes breast tumor growth by regulating the Wnt signaling pathway
Cai Y, He J, Zhang D
OncoTargets and Therapy 2015, 8:2657-2664
Published Date: 21 September 2015
Diarrhea as initial manifestation of pulmonary artery intimal sarcoma: a case report and literature review
Xu X, Zhang R, Hu H, Ye W, Wang J, Chen L, Qiu L, Ying K
OncoTargets and Therapy 2015, 8:2651-2656
Published Date: 18 September 2015
Combination of Bcl-2 and MYC protein expression improves high-risk stratification in diffuse large B-cell lymphoma
Wang J, Zhou M, Xu JY, Chen B, Ouyang J
OncoTargets and Therapy 2015, 8:2645-2650
Published Date: 18 September 2015
Comparing two assays for clinical genomic profiling: the devil is in the data [Letter of clarification]
Weiss GJ, Khemka V
OncoTargets and Therapy 2015, 8:2643-2644
Published Date: 18 September 2015
miR-205 suppresses the proliferative and migratory capacity of human osteosarcoma MG-63 cells by targeting VEGFA
Wang L, Shan M, Yang F, Liu Y, Qi H, Zhou L, Qiu L, Li Y
OncoTargets and Therapy 2015, 8:2635-2642
Published Date: 16 September 2015
Polymorphism in miR-146a associated with clinical characteristics and outcomes in gastric cancer patients treated with adjuvant oxaliplatin and fluoropyrimidines
Liao YQ, Liao YL, Li J, Peng LX, Wan YY, Zhong R
OncoTargets and Therapy 2015, 8:2627-2633
Published Date: 16 September 2015
The expression status and prognostic significance of programmed cell death 1 ligand 1 in gastrointestinal tract cancer: a systematic review and meta-analysis
Huang B, Chen L, Bao C, Sun C, Li J, Wang L, Zhang X
OncoTargets and Therapy 2015, 8:2617-2625
Published Date: 15 September 2015
Role of DFNA5 in hearing loss and cancer – a comment on Rakusic et al
Croes L, Op de Beeck K, Van Camp G
OncoTargets and Therapy 2015, 8:2613-2615
Published Date: 15 September 2015
Liposomal curcumin inhibits hypoxia-induced angiogenesis after transcatheter arterial embolization in VX2 rabbit liver tumors
Dai F, Zhang XM, Shen WR, Chen J, Liu LC, Gao GJ
OncoTargets and Therapy 2015, 8:2601-2611
Published Date: 15 September 2015
Increased serum levels of interleukin-10 predict poor prognosis in extranodal natural killer/T-cell lymphoma patients receiving asparaginase-based chemotherapy
Wang H, Wang L, Wuxiao ZJ, Huang HQ, Jiang WQ, Li ZM, Lu Y, Xia ZJ
OncoTargets and Therapy 2015, 8:2589-2599
Published Date: 14 September 2015
Protein tyrosine phosphatase SHP-1 sensitizes EGFR/HER-2 positive breast cancer cells to trastuzumab through modulating phosphorylation of EGFR and HER-2
Wu YF, Li R, Zhang JY, Wang G, Liu B, Huang XF, Zhang T, Luo RC
OncoTargets and Therapy 2015, 8:2577-2587
Published Date: 14 September 2015
Expression of Fascin-1 on human lung cancer and paracarcinoma tissue and its relation to clinicopathological characteristics in patients with lung cancer
Zhao W, Gao J, Wu J, Liu Q, Wang Z, Li H, Xing L
OncoTargets and Therapy 2015, 8:2571-2576
Published Date: 15 September 2015
Prognostic role of LSD1 in various cancers: evidence from a meta-analysis
Wu J, Hu LX, Du YY, Kong FL, Pan YY
OncoTargets and Therapy 2015, 8:2565-2570
Published Date: 15 September 2015
The engineered Salmonella typhimurium inhibits tumorigenesis in advanced glioma
Chen JQ, Zhan YF, Wang W, Jiang SN, Li XY
OncoTargets and Therapy 2015, 8:2555-2563
Published Date: 15 September 2015
Different setup errors assessed by weekly cone-beam computed tomography on different registration in nasopharyngeal carcinoma treated with intensity-modulated radiation therapy
Su JQ, Chen W, Yang HY, Hong JD, Zhang ZJ, Yang GZ, Li L, Wei R
OncoTargets and Therapy 2015, 8:2545-2553
Published Date: 14 September 2015
New developments in the management of advanced melanoma – role of pembrolizumab
Improta G, Leone I, Donia M, Gieri S, Pelosi G, Fraggetta F
OncoTargets and Therapy 2015, 8:2535-2543
Published Date: 14 September 2015
The clinical analysis of acute pancreatitis in colorectal cancer patients undergoing chemotherapy after operation
Ji YL, Han Z, Shao LM, Li YL, Zhao L, Zhao YH
OncoTargets and Therapy 2015, 8:2527-2533
Published Date: 11 September 2015
Association between promoter polymorphisms of matrix metalloproteinase-1 and risk of gastric cancer
Peng QS, Xu Y
OncoTargets and Therapy 2015, 8:2519-2526
Published Date: 10 September 2015
The expression and clinical significance of HDGF in osteosarcoma
Chen Z, Qiu S, Lu X
OncoTargets and Therapy 2015, 8:2509-2517
Published Date: 9 September 2015
Treatment and survival analyses of completely resected thymic carcinoma patients
Mao Y, Wu S
OncoTargets and Therapy 2015, 8:2503-2507
Published Date: 9 September 2015
Association between the polymorphisms of urokinase plasminogen activation system and cancer risk: a meta-analysis
Xu Z, Meng LL, Lin JZ, Ling Y, Chen SX, Lin N
OncoTargets and Therapy 2015, 8:2493-2502
Published Date: 9 September 2015
Comparison of the utility and applicability of the Sokal, Hasford, and EUTOS scores in a population of Chinese patients with chronic-phase chronic myeloid leukemia undergoing imatinib therapy
Xia L, Qian W, Yang M, Li Q, Liu F, Xie Y
OncoTargets and Therapy 2015, 8:2485-2492
Published Date: 7 September 2015
GSTM1 null genotype may be associated with an increased nasopharyngeal cancer risk in South China: an updated meta-analysis and review
Li YN, Wan WH, Li T, Cao J, Xu G
OncoTargets and Therapy 2015, 8:2479-2484
Published Date: 7 September 2015
Thyroid transcription factor-1 expression is significantly associated with mutations in exon 21 of the epidermal growth factor receptor gene in Chinese patients with lung adenocarcinoma
Zhao QC, Xu S, Liu JH, Li Y, Fan YG, Shi T, Wei S, Tang SC, Liu HY, Chen J
OncoTargets and Therapy 2015, 8:2469-2478
Published Date: 7 September 2015
Three-dimensional conformal radiotherapy by delineations on CT-based simulation in different respiratory phases for the treatment of senile patients with non-small cell lung cancer
Wang WF, Yuan F, Wang GP, Lin ZR, Pan YL, Chen LH
OncoTargets and Therapy 2015, 8:2461-2467
Published Date: 7 September 2015
No associations between aromatase gene polymorphisms and breast cancer risk in Saudi patients
Alanazi M, Alabdulkarim HA, Shaik JP, Al Naeem A, Elrobh M, Al Amri A, al-Mukaynizi FB, Semlali A, Warsy A, Parine NR
OncoTargets and Therapy 2015, 8:2453-2459
Published Date: 3 September 2015
A common genetic variation in CEBPE and acute lymphoblastic leukemia: a meta-analysis of the available evidence
Zhang XX, Du YF, Zhai YJ, Gao F, Yang YJ, Ma XC, Lu J, Zheng J
OncoTargets and Therapy 2015, 8:2443-2451
Published Date: 7 September 2015
Treatment compliance and severe adverse events limit the use of tyrosine kinase inhibitors in refractory thyroid cancer
Chrisoulidou A, Mandanas S, Margaritidou E, Mathiopoulou L, Boudina M, Georgopoulos K, Pazaitou-Panayiotou K
OncoTargets and Therapy 2015, 8:2435-2442
Published Date: 3 September 2015
The expression of the PI3K/AKT/mTOR pathway in gastric cancer and its role in gastric cancer prognosis
Ying J, Xu Q, Liu B, Zhang G, Chen L, Pan H
OncoTargets and Therapy 2015, 8:2427-2433
Published Date: 1 September 2015
Dietary fiber, whole grains, carbohydrate, glycemic index, and glycemic load in relation to risk of prostate cancer
Wang RJ, Tang JE, Chen Y, Gao JG
OncoTargets and Therapy 2015, 8:2415-2426
Published Date: 2 September 2015
Bevacizumab plus chemotherapy as third- or later-line therapy in patients with heavily treated metastatic colorectal cancer
Yang Q, Yin CX, Liao FX, Huang YY, He WZ, Jiang C, Guo GF, Zhang B, Xia LP
OncoTargets and Therapy 2015, 8:2407-2413
Published Date: 1 September 2015
The distinctive nature of adenocarcinoma of the lung
Roviello G
OncoTargets and Therapy 2015, 8:2399-2406
Published Date: 2 September 2015
Profile of obinutuzumab for the treatment of patients with previously untreated chronic lymphocytic leukemia
Hill BT, Kalaycio M
OncoTargets and Therapy 2015, 8:2391-2397
Published Date: 31 August 2015
Chronic neutrophilic leukemia: a clinical perspective
Menezes J, Cigudosa JC
OncoTargets and Therapy 2015, 8:2383-2390
Published Date: 1 September 2015
The impact of histological types on the efficacy of angiogenesis inhibitors in the treatment of advanced NSCLC: a meta-analysis of randomized controlled trials
Zhang J, Liu J, Chen HG, Wu WB, Li XJ, Wu YH, Zhang K, Gu LJ
OncoTargets and Therapy 2015, 8:2375-2382
Published Date: 31 August 2015
Increased risk of severe infections in cancer patients treated with vascular endothelial growth factor receptor tyrosine kinase inhibitors: a meta-analysis
Ma Q, Gu LY, Ren YY, Zeng LL, Gong T, Zhong DS
OncoTargets and Therapy 2015, 8:2361-2374
Published Date: 28 August 2015
Apoptotic effect of cordycepin combined with cisplatin and/or paclitaxel on MA-10 mouse Leydig tumor cells
Kang FC, Chen PJ, Pan BS, Lai MS, Chen YC, Huang BM
OncoTargets and Therapy 2015, 8:2345-2360
Published Date: 1 September 2015
The prognosis factor of adjuvant radiation therapy after surgery in uterine sarcomas
Hou HL, Meng MB, Chen XL, Zhao LJ, Zhu L, Zhang BL, Wang P
OncoTargets and Therapy 2015, 8:2339-2344
Published Date: 28 August 2015
Clinical and prognostic significance of pathological and inflammatory markers in the surgical treatment of locally advanced colorectal cancer
Sokolov M, Angelov K, Vasileva M, Atanasova MP, Vlahova A, Todorov G
OncoTargets and Therapy 2015, 8:2329-2337
Published Date: 1 September 2015
Micheliolide overcomes KLF4-mediated cisplatin resistance in breast cancer cells by downregulating glutathione
Jia Y, Zhang C, Zhou L, Xu H, Shi Y, Tong Z
OncoTargets and Therapy 2015, 8:2319-2327
Published Date: 28 August 2015
Screening of feature genes in distinguishing different types of breast cancer using support vector machine
Wang Q, Liu XD
OncoTargets and Therapy 2015, 8:2311-2317
Published Date: 27 August 2015
Microvascular invasion in hepatocellular carcinoma overexpression promotes cell proliferation and inhibits cell apoptosis of hepatocellular carcinoma via inhibiting miR-199a expression
Shi Y, Song Q, Yu S, Hu D, Zhuang X
OncoTargets and Therapy 2015, 8:2303-2310
Published Date: 27 August 2015
Genetic polymorphisms of PAI-1 and PAR-1 are associated with acute normal tissue toxicity in Chinese rectal cancer patients treated with pelvic radiotherapy
Zhang H, Wang M, Shi T, Shen L, Zhu J, Sun M, Deng Y, Liang L, Li G, Wu Y, Fan M, Wei Q, Zhang Z
OncoTargets and Therapy 2015, 8:2291-2301
Published Date: 27 August 2015
Effects of magnetic nanoparticles of Fe3O4 combinated with gambogic acid on apoptosis of SMMC-7721 cells
Tian L, Chen BA, Cheng J, Guo QL
OncoTargets and Therapy 2015, 8:2285-2290
Published Date: 26 August 2015
Prognostic value of FDG PET/CT in head and neck squamous cell carcinomas
Dequanter D, Shahla M, Aubert C, Deniz Y, Lothaire P
OncoTargets and Therapy 2015, 8:2279-2283
Published Date: 26 August 2015
Expression profiles of pivotal microRNAs and targets in thyroid papillary carcinoma: an analysis of The Cancer Genome Atlas
Cong D, He MZ, Chen SL, Liu XL, Liu XD, Sun H
OncoTargets and Therapy 2015, 8:2271-2277
Published Date: 26 August 2015
Cemented allograft-prosthesis composite reconstruction for the proximal femur tumor
Min L, Tang F, Duan H, Zhou Y, Zhang WL, Shi R, Tu CQ
OncoTargets and Therapy 2015, 8:2261-2269
Published Date: 25 August 2015
Trametinib: a MEK inhibitor for management of metastatic melanoma
Lugowska I, Koseła-Paterczyk H, Kozak K, Rutkowski P
OncoTargets and Therapy 2015, 8:2251-2259
Published Date: 25 August 2015
Expressions and clinical significance of autophagy-related markers Beclin1, LC3, and EGFR in human cervical squamous cell carcinoma
Hu YF, Lei X, Zhang HY, Ma JW, Yang WW, Chen ML, Cui J, Zhao H
OncoTargets and Therapy 2015, 8:2243-2249
Published Date: 24 August 2015
Comparing two assays for clinical genomic profiling: the devil is in the data
Squillace RM, Frampton GM, Stephens PJ, Ross JS, Miller VA
OncoTargets and Therapy 2015, 8:2237-2242
Published Date: 24 August 2015
MicroRNA-212 inhibits hepatocellular carcinoma cell proliferation and induces apoptosis by targeting FOXA1
Tu H, Wei G, Cai Q, Chen X, Sun Z, Cheng C, Zhang L, Feng Y, Zhou H, Zhou B, Zeng T
OncoTargets and Therapy 2015, 8:2227-2235
Published Date: 24 August 2015
The influence of TLR4 agonist lipopolysaccharides on hepatocellular carcinoma cells and the feasibility of its application in treating liver cancer
Gu J, Sun R, Shen S, Yu Z
OncoTargets and Therapy 2015, 8:2215-2225
Published Date: 21 August 2015
Retrospective study of irinotecan/cisplatin followed by etoposide/cisplatin or the reverse sequence in extensive-stage small cell lung cancer
Xiao XG, Wang SJ, Xia S, Zou M, Li Y, Wei Y, Mei Q, Chen Y
OncoTargets and Therapy 2015, 8:2209-2214
Published Date: 21 August 2015
Disruption of NF-κB signaling by fluoxetine attenuates MGMT expression in glioma cells
Song T, Li H, Tian Z, Xu C, Liu J, Guo Y
OncoTargets and Therapy 2015, 8:2199-2208
Published Date: 20 August 2015
Epothilones in epithelial ovarian, fallopian tube, or primary peritoneal cancer: a systematic review
Zagouri F, Sergentanis TN, Chrysikos D, Dimopoulos MA, Bamias A
OncoTargets and Therapy 2015, 8:2187-2198
Published Date: 20 August 2015
The association between miR-499 polymorphism and cancer susceptibility: a meta-analysis
Xu Z, Zhang E, Duan W, Sun C, Bai S, Tan X
OncoTargets and Therapy 2015, 8:2179-2186
Published Date: 20 August 2015
Morphologic patterns and imaging features of intracranial hemangiopericytomas: a retrospective analysis
Pang HP, Yao ZW, Ren Y, Liu GB, Zhang JW, Feng XY
OncoTargets and Therapy 2015, 8:2169-2178
Published Date: 20 August 2015
Merkel cell carcinoma of the head and neck: pathogenesis, current and emerging treatment options
Saini AT, Miles BA
OncoTargets and Therapy 2015, 8:2157-2167
Published Date: 19 August 2015
Current and emerging treatment options for hairy cell leukemia
López-Rubio M, Garcia-Marco JA
OncoTargets and Therapy 2015, 8:2147-2156
Published Date: 19 August 2015
Clinical efficacy of percutaneous vertebroplasty combined with intensity-modulated radiotherapy for spinal metastases in patients with NSCLC
Li Y, Qing Y, Zhang ZM, Li MX, Xie JY, Wang G, Wang D
OncoTargets and Therapy 2015, 8:2139-2145
Published Date: 19 August 2015
Simultaneous hepatectomy and splenectomy versus hepatectomy alone for hepatocellular carcinoma complicated by hypersplenism: a meta-analysis
Li W, Shen SQ, Wu SM, Chen ZB, Hu C, Yan RC
OncoTargets and Therapy 2015, 8:2129-2137
Published Date: 19 August 2015
Alteration of ASIC1 expression in clear cell renal cell carcinoma
Li Y, Xu G, Huang K, Wang J, Zhang J, Liu J, Wang Z, Chen G
OncoTargets and Therapy 2015, 8:2121-2127
Published Date: 14 August 2015
CAG repeat polymorphisms in the androgen receptor and breast cancer risk in women: a meta-analysis of 17 studies
Mao Q, Qiu M, Dong G, Xia W, Zhang S, Xu Y, Wang J, Rong Y, Xu L, Jiang F
OncoTargets and Therapy 2015, 8:2111-2120
Published Date: 13 August 2015
Hepatoma-derived growth factor predicts unfavorable prognosis of epithelial ovarian cancer
Liu XJ, Liu WL, Yang FM, Yang XQ, Lu XF
OncoTargets and Therapy 2015, 8:2101-2109
Published Date: 13 August 2015
A recurrent ovarian cancer patient with a history of nine prior chemotherapy regimens who was safely treated with weekly paclitaxel plus bevacizumab and achieved a complete response: a case report
Takatori E, Shoji T, Nagasawa T, Takeuchi S, Hosoyachi A, Sugiyama T
OncoTargets and Therapy 2015, 8:2097-2100
Published Date: 11 August 2015
Urine microRNAs as biomarkers for bladder cancer: a diagnostic meta-analysis
Cheng Y, Deng X, Yang X, Li P, Zhang X, Li P, Tao J, Lu Q, Wang Z
OncoTargets and Therapy 2015, 8:2089-2096
Published Date: 11 August 2015
Heme oxygenase-1 is a predictive biomarker for therapeutic targeting of advanced clear cell renal cell carcinoma treated with sorafenib or sunitinib
Zheng WX, Yan F, Xue Q, Wu GJ, Qin WJ, Wang FL, Qin J, Tian CJ, Yuan JL
OncoTargets and Therapy 2015, 8:2081-2088
Published Date: 10 August 2015
A polymorphism at the microRNA binding site in the 3' untranslated region of RYR3 is associated with outcome in hepatocellular carcinoma
Peng CX, Guo ZJ, Wu XY, Zhang XL
OncoTargets and Therapy 2015, 8:2075-2079
Published Date: 10 August 2015
RETRACTED ARTICLE: PP4R1 accelerates cell growth and proliferation in HepG2 hepatocellular carcinoma
Wu G, Ma ZY, Qian JM, Liu B
OncoTargets and Therapy 2015, 8:2067-2074
Published Date: 7 August 2015
Phytochemicals modulate carcinogenic signaling pathways in breast and hormone-related cancers
Cojocneanu Petric R, Braicu C, Raduly L, Zanoaga O, Dragos N, Monroig P, Dumitrascu D, Berindan-Neagoe I
OncoTargets and Therapy 2015, 8:2053-2066
Published Date: 6 August 2015
Nivolumab in the treatment of malignant melanoma: review of the literature
Mashima E, Inoue A, Sakuragi Y, Yamaguchi T, Sasaki N, Hara Y, Omoto D, Ohmori S, Haruyama S, Sawada Y, Yoshioka M, Nishio D, Nakamura M
OncoTargets and Therapy 2015, 8:2045-2051
Published Date: 6 August 2015
Meta-analysis of postoperative adjuvant chemotherapy without radiotherapy in early stage non-small cell lung cancer
Chen YY, Wang LW, Wang SY, Wu BB, Wang ZM, Chen FF, Xiong B
OncoTargets and Therapy 2015, 8:2033-2043
Published Date: 4 August 2015
Efficacy and safety of docetaxel for advanced non-small-cell lung cancer: a meta-analysis of Phase III randomized controlled trials
He X, Wang J, Li Y
OncoTargets and Therapy 2015, 8:2023-2031
Published Date: 4 August 2015
Computer-aided classification of lung nodules on computed tomography images via deep learning technique
Hua KL, Hsu CH, Hidayati SC, Cheng WH, Chen YJ
OncoTargets and Therapy 2015, 8:2015-2022
Published Date: 4 August 2015
Associations between deepness of response and clinical outcomes among Japanese patients with metastatic colorectal cancer treated with second-line FOLFIRI plus cetuximab
Osumi H, Matsusaka S, Suenaga M, Shinozaki E, Mizunuma N
OncoTargets and Therapy 2015, 8:2005-2013
Published Date: 6 August 2015
Inactivity of imatinib in gastrointestinal stromal tumors (GISTs) harboring a KIT activation-loop domain mutation (exon 17 mutation pN822K)
Spitaleri G, Biffi R, Barberis M, Fumagalli C, Toffalorio F, Catania C, Noberasco C, Lazzari C, de Marinis F, De Pas T
OncoTargets and Therapy 2015, 8:1997-2003
Published Date: 18 August 2015
Dynamic monitoring of plasma amino acids and carnitine during chemotherapy of patients with alimentary canal malignancies and its clinical value
Wang XY, Wang JQ, Wang ZH, Wang QJ, Li H
OncoTargets and Therapy 2015, 8:1989-1996
Published Date: 7 August 2015
The histone demethylase PHF8 promotes prostate cancer cell growth by activating the oncomiR miR-125b
Ma Q, Chen Z, Jia G, Lu X, Xie X, Jin W
OncoTargets and Therapy 2015, 8:1979-1988
Published Date: 10 August 2015
Low claudin-6 expression correlates with poor prognosis in patients with non-small cell lung cancer
Wang Q, Zhang Y, Zhang T, Han ZG, Shan L
OncoTargets and Therapy 2015, 8:1971-1977
Published Date: 31 July 2015
The role of 18F-FDG PET/CT imaging in patient with malignant PEComa treated with mTOR inhibitor
Sun L, Sun XR, Li YH, Xing LG
OncoTargets and Therapy 2015, 8:1967-1970
Published Date: 30 July 2015
−148 C/T polymorphism of Axin2 contributes to a decreased risk of cancer: evidence from a meta-analysis
Zhong AY, Pan X, Shi MH, Xu HJ
OncoTargets and Therapy 2015, 8:1957-1966
Published Date: 29 July 2015
Prognostic value of IGF-1R expression in bone and soft tissue sarcomas: a meta-analysis
Liang JB, Li BH, Yuan L, Ye ZM
OncoTargets and Therapy 2015, 8:1949-1955
Published Date: 29 July 2015
Hypoxia-inducible factor-1α induces multidrug resistance protein in colon cancer
Lv Y, Zhao S, Han J, Zheng L, Yang Z, Zhao L
OncoTargets and Therapy 2015, 8:1941-1948
Published Date: 29 July 2015
Profile of veliparib and its potential in the treatment of solid tumors
Wagner LM
OncoTargets and Therapy 2015, 8:1931-1939
Published Date: 29 July 2015
Determination and validation of mTOR kinase-domain 3D structure by homology modeling
Lakhlili W, Chevé G, Yasri A, Ibrahimi A
OncoTargets and Therapy 2015, 8:1923-1930
Published Date: 30 July 2015
Whole blood defensin mRNA expression is a predictive biomarker of docetaxel response in castration-resistant prostate cancer
Kohli M, Young CYF, Tindall DJ, Nandy D, McKenzie KM, Bevan GH, Donkena KV
OncoTargets and Therapy 2015, 8:1915-1922
Published Date: 30 July 2015
Malignant glomus tumor of the lung with multiorgan metastases: case report and literature review
Dong LL, Chen EG, Sheikh IS, Jiang ZN, Huang AH, Ying KJ
OncoTargets and Therapy 2015, 8:1909-1914
Published Date: 28 July 2015
Peritumoral SPARC expression and patient outcome with resectable intrahepatic cholangiocarcinoma
Cheng CT, Chu YY, Yeh CN, Huang SC, Chen MH, Wang SY, Tsai CY, Chiang KC, Chen YY, Ma MC, Liu CT, Chen TW, Yeh TS
OncoTargets and Therapy 2015, 8:1899-1907
Published Date: 28 July 2015
The expression and significance of Gal-3 and MUC1 in colorectal cancer and colon cancer
Wang H, Wang L
OncoTargets and Therapy 2015, 8:1893-1898
Published Date: 27 July 2015
Is there any association between hormonal contraceptives and cervical neoplasia in a poor Nigerian setting?
Ajah LO, Chigbu CO, Ozumba BC, Oguanuo TC, Ezeonu PO
OncoTargets and Therapy 2015, 8:1887-1892
Published Date: 27 July 2015
Investigation of brain tumors using 18F-fluorobutyl ethacrynic amide and its metabolite with positron emission tomography
Huang YC, Huang HL, Yeh CN, Lin KJ, Yu CS
OncoTargets and Therapy 2015, 8:1877-1885
Published Date: 24 July 2015
miR-20b overexpression is predictive of poor prognosis in gastric cancer
Xue TM, Tao LD, Zhang M, Xu GC, Zhang J, Zhang PJ
OncoTargets and Therapy 2015, 8:1871-1876
Published Date: 24 July 2015
p27Kip1 and Ser10-phosphorylated p27Kip1 in breast cancer: clinical significance and expression
Song W, Xie RL, Zhu AY, Xu YM, Shi YQ, Shen Y, Zhang WW, Yang F, Guan XX
OncoTargets and Therapy 2015, 8:1863-1869
Published Date: 24 July 2015
Quantitative assessment of pre-miR-218 rs11134527 polymorphism and cancer risk in Chinese population
Zhao HY, Wang R
OncoTargets and Therapy 2015, 8:1859-1862
Published Date: 24 July 2015
Ganetespib: research and clinical development
Jhaveri K, Modi S
OncoTargets and Therapy 2015, 8:1849-1858
Published Date: 24 July 2015
Expression of ARs in triple negative breast cancer tumors: a potential prognostic factor?
Giannos A, Filipits M, Zagouri F, Brandstetter A, Tsigginou A, Sotiropoulou M, Papaspyrou I, Sergentanis TN, Psaltopoulou T, Rodolakis A, Antsaklis A, Dimopoulos MA, Dimitrakakis C
OncoTargets and Therapy 2015, 8:1843-1847
Published Date: 23 July 2015
Association between GSTP1 polymorphisms and prognosis of osteosarcoma in patients treated with chemotherapy: a meta-analysis
Pu FF, Chen FX, Chen SF, Wang BC, Liu JX, Shao ZW
OncoTargets and Therapy 2015, 8:1835-1842
Published Date: 23 July 2015
Expression of PD-1 by CD4+CD25+CD127low Treg cells in the peripheral blood of lung cancer patients
Zhong AY, Pan X, Shi MH
OncoTargets and Therapy 2015, 8:1831-1833
Published Date: 23 July 2015
Follicular dendritic cell sarcoma: two rare cases and a brief review of the literature
Ma Y, Sun JJ, Yang CC, Yuan DD, Liu J
OncoTargets and Therapy 2015, 8:1823-1830
Published Date: 24 July 2015
Diffuse anterior retinoblastoma: current concepts
Yang J, Dang Y, Zhu Y, Zhang C
OncoTargets and Therapy 2015, 8:1815-1821
Published Date: 22 July 2015
Upregulation of nucleostemin in colorectal cancer and its effects on cell malignancy
Wei B, Huang Q, Zhong X
OncoTargets and Therapy 2015, 8:1805-1814
Published Date: 21 July 2015
Identification of the key genes connected with plasma cells of multiple myeloma using expression profiles
Zhang K, Xu Z, Sun Z
OncoTargets and Therapy 2015, 8:1795-1803
Published Date: 20 July 2015
MTA1 promotes proliferation and invasion in human gastric cancer cells
Yao Y, Feng S, Xiao M, Li Y, Yang L, Gong J
OncoTargets and Therapy 2015, 8:1785-1794
Published Date: 20 July 2015
miR-32 functions as a tumor suppressor and directly targets SOX9 in human non-small cell lung cancer
Zhu D, Chen H, Yang X, Chen W, Wang L, Xu J, Yu L
OncoTargets and Therapy 2015, 8:1773-1783
Published Date: 20 July 2015
Volasertib for AML: clinical use and patient consideration
Hao Z, Kota V
OncoTargets and Therapy 2015, 8:1761-1771
Published Date: 17 July 2015
IL-2 -330T/G polymorphism and cancer risk: a meta-analysis
Zhao HY, Wang R
OncoTargets and Therapy 2015, 8:1753-1760
Published Date: 17 July 2015
Comparison of dynamic contrast-enhanced magnetic resonance imaging with T2-weighted imaging for preoperative staging of early endometrial carcinoma
Zheng L, Zheng S, Yuan X, Wang X, Zhang Z, Zhang G
OncoTargets and Therapy 2015, 8:1743-1751
Published Date: 17 July 2015
Single nucleotide polymorphisms of microRNA processing genes and outcome of non-Hodgkin’s lymphoma
Gao Y, Diao L, Li H, Guo Z
OncoTargets and Therapy 2015, 8:1735-1741
Published Date: 15 July 2015
B7-H3 silencing by RNAi inhibits tumor progression and enhances chemosensitivity in U937 cells
Zhang W, Wang J, Wang Y, Dong F, Zhu M, Wan W, Li H, Wu F, Yan X, Ke X
OncoTargets and Therapy 2015, 8:1721-1733
Published Date: 14 July 2015
A tale of the two PEGylated liposomal doxorubicins
Chou HH, Lin H, Liu JM
OncoTargets and Therapy 2015, 8:1719-1720
Published Date: 13 July 2015
The prognostic significance of protein tyrosine phosphatase 4A2 in breast cancer
Zhao D, Guo L, Neves H, Yuen HF, Zhang SD, McCrudden CM, Wen Q, Zhang J, Zeng Q, Kwok HF, Lin Y
OncoTargets and Therapy 2015, 8:1707-1717
Published Date: 13 July 2015
Significance of downregulation of renal organic cation transporter (SLC47A1) in cisplatin-induced proximal tubular injury
Mizuno T, Sato W, Ishikawa K, Terao Y, Takahashi K, Noda Y, Yuzawa Y, Nagamatsu T
OncoTargets and Therapy 2015, 8:1701-1706
Published Date: 10 July 2015
Screening of potential diagnostic markers and therapeutic targets against colorectal cancer
Tian XQ, Sun DF, Zhao SL, Xiong H, Fang JY
OncoTargets and Therapy 2015, 8:1691-1699
Published Date: 8 July 2015
AKT2-knockdown suppressed viability with enhanced apoptosis, and attenuated chemoresistance to temozolomide of human glioblastoma cells in vitro and in vivo
Cui Y, Lin J, Zuo JL, Zhang L, Dong Y, Hu GH, Luo C, Chen JX, Lu YC
OncoTargets and Therapy 2015, 8:1681-1690
Published Date: 8 July 2015
Association between EHBP1 rs721048(A>G) polymorphism and prostate cancer susceptibility: a meta-analysis of 17 studies involving 150,678 subjects
Ao X, Liu Y, Bai XY, Qu X, Xu Z, Hu G, Chen M, Wu H
OncoTargets and Therapy 2015, 8:1671-1680
Published Date: 7 July 2015
FH535 inhibited metastasis and growth of pancreatic cancer cells
Wu MY, Liang RR, Chen K, Shen M, Tian YL, Li DM, Duan WM, Gui Q, Gong FR, Lian L, Li W, Tao M
OncoTargets and Therapy 2015, 8:1651-1670
Published Date: 6 July 2015
High expression of UBD correlates with epirubicin resistance and indicates poor prognosis in triple-negative breast cancer
Tao H, Liu Z, Li H, Xie W, Zhang R, Zhu L, Guo F, Han Y, Sheng Y, Xie X
OncoTargets and Therapy 2015, 8:1643-1649
Published Date: 6 July 2015
Mixed acinar-endocrine carcinoma of pancreas: a case report and brief review of the literature
Liu Z, Dong C, Wang C, Liu Q, Sun D, Wang L
OncoTargets and Therapy 2015, 8:1633-1642
Published Date: 3 July 2015
Microwave ablation: state-of-the-art review
Hernández JI, Cepeda MFJ, Valdés F, Guerrero GD
OncoTargets and Therapy 2015, 8:1627-1632
Published Date: 6 July 2015
Expression of MMP-1/PAR-1 and patterns of invasion in oral squamous cell carcinoma as potential prognostic markers
Fan HX, Chen Y, Ni BX, Wang S, Sun M, Chen D, Zheng JH
OncoTargets and Therapy 2015, 8:1619-1626
Published Date: 3 July 2015
Cytochrome P450 1A1 exon 7 polymorphism and susceptibility to lung cancer in the Chinese population: an updated meta-analysis and review
Wei X, Hu J
OncoTargets and Therapy 2015, 8:1611-1618
Published Date: 2 July 2015
Gefitinib upregulates death receptor 5 expression to mediate rmhTRAIL-induced apoptosis in Gefitinib-sensitive NSCLC cell line
Yan D, Ge Y, Deng H, Chen W, An G
OncoTargets and Therapy 2015, 8:1603-1610
Published Date: 3 July 2015
Rapidly progressive stage IVB mycosis fungoides treated with low-dose total skin electron beam therapy
Chowdhary M, Kabbani AA, Rimtepathip P, Cole Jr DA, Cohen DJ
OncoTargets and Therapy 2015, 8:1597-1601
Published Date: 1 July 2015
Clinicopathological significance of fascin-1 expression in patients with non-small cell lung cancer
Ling XL, Zhang T, Hou XM, Zhao D
OncoTargets and Therapy 2015, 8:1589-1595
Published Date: 30 June 2015
Prognostic analysis of Chinese patients with metastasis renal cell cancer receiving sorafenib: results from a multicenter long-term follow-up retrospective study
Guo F, Han T, Liu Z, Song X, Zhang Q, Kong X, Li C, Li Z, Li C, Qu S, Zheng Z, Piao Y, Han Y, Xie X
OncoTargets and Therapy 2015, 8:1581-1588
Published Date: 26 June 2015
Single-port versus conventional multiport access prophylactic laparoscopic bilateral salpingo-oophorectomy in high-risk patients for ovarian cancer: a comparison of surgical outcomes
Angioni S, Pontis A, Sedda F, Zampetoglou T, Cela V, Mereu L, Litta P
OncoTargets and Therapy 2015, 8:1575-1580
Published Date: 25 June 2015
Profile of blinatumomab and its potential in the treatment of relapsed/refractory acute lymphoblastic leukemia
Ribera JM, Ferrer A, Ribera J, Genescà E
OncoTargets and Therapy 2015, 8:1567-1574
Published Date: 24 June 2015
Role of integrin-linked kinase in drug resistance of lung cancer
Jia Z
OncoTargets and Therapy 2015, 8:1561-1565
Published Date: 23 June 2015
Enhanced NK cell adoptive antitumor effects against breast cancer in vitro via blockade of the transforming growth factor-β signaling pathway
Zhao Y, Hu JY, Li RG, Song J, Kang YJ, Liu S, Zhang DW
OncoTargets and Therapy 2015, 8:1553-1559
Published Date: 22 June 2015
Roles of dopamine receptors and their antagonist thioridazine in hepatoma metastasis
Lu M, Li J, Luo Z, Zhang S, Xue S, Wang K, Shi Y, Zhang C, Chen H, Li Z
OncoTargets and Therapy 2015, 8:1543-1552
Published Date: 22 June 2015
Detection of epidermal growth factor receptor mutation in lung cancer by droplet digital polymerase chain reaction
Xu Q, Zhu Y, Bai Y, Wei X, Zheng X, Mao M, Zheng G
OncoTargets and Therapy 2015, 8:1533-1541
Published Date: 22 June 2015
Anterior gradient protein 3 is associated with less aggressive tumors and better outcome of breast cancer patients
Obacz J, Brychtova V, Podhorec J, Fabian P, Dobes P, Vojtesek B, Hrstka R
OncoTargets and Therapy 2015, 8:1523-1532
Published Date: 24 June 2015
Evaluation of the pathological response and prognosis following neoadjuvant chemotherapy in molecular subtypes of breast cancer
Zhao Y, Dong XQ, Li RG, Ma X, Song J, Li YJ, Zhang DW
OncoTargets and Therapy 2015, 8:1511-1521
Published Date: 19 June 2015
Prognostic role of urokinase plasminogen activator receptor in gastric and colorectal cancer: a systematic review and meta-analysis
Guo H, Ling C, Ma YY, Zhou LX, Zhao L
OncoTargets and Therapy 2015, 8:1503-1509
Published Date: 19 June 2015
Axillary and internal mammary sentinel lymph node biopsy in male breast cancer patients: case series and review
Cao X, Wang C, Liu Y, Qiu P, Cong B, Wang Y
OncoTargets and Therapy 2015, 8:1499-1502
Published Date: 17 June 2015
IL-27 rs153109 polymorphism increases the risk of colorectal cancer in Chinese Han population
Lyu SX, Ye LC, Wang OC, Huang GL, Yang F, Liu YH, Dong SY
OncoTargets and Therapy 2015, 8:1493-1497
Published Date: 16 June 2015
Exploration of peptide T7 and its derivative as integrin αvβ3-targeted imaging agents
He X, Hao Y, Long W, Song N, Fan S, Meng A
OncoTargets and Therapy 2015, 8:1483-1491
Published Date: 15 June 2015
Prognostic role of HOTAIR in four estrogen-dependent malignant tumors: a meta-analysis
Li J, Wen W, Zhao S, Wang JX, Chen JY, Wang YR, Zhang QY
OncoTargets and Therapy 2015, 8:1471-1482
Published Date: 15 June 2015
Bortezomib-based vs non-bortezomib-based post-transplantation treatment in multiple myeloma patients: a systematic review and meta-analysis of Phase III randomized controlled trials
Liu XP, He CK, Meng XY, He L, Li KL, Liang Q, Shao L, Liu SQ
OncoTargets and Therapy 2015, 8:1459-1469
Published Date: 15 June 2015
Positive expression of programmed death ligand-1 correlates with superior outcomes and might be a therapeutic target in primary pulmonary lymphoepithelioma-like carcinoma
Jiang L, Wang L, Li PF, Zhang XK, Chen JW, Qiu HJ, Wu XD, Zhang B
OncoTargets and Therapy 2015, 8:1451-1457
Published Date: 15 June 2015
CpG oligodeoxyribonucleotide 7909 enhances radiosensitivity via downregulating Oct-4 expression in radioresistant lung cancer cells
Xing N, Qiao T, Zhuang X, Yuan S, Zhang Q, Xu G
OncoTargets and Therapy 2015, 8:1443-1449
Published Date: 12 June 2015
Tamoxifen with ovarian function suppression versus tamoxifen alone as an adjuvant treatment for premenopausal breast cancer: a meta-analysis of published randomized controlled trials
Yan S, Li K, Jiao X, Zou H
OncoTargets and Therapy 2015, 8:1433-1441
Published Date: 12 June 2015
Analysis of clinical efficacy of CyberKnife® treatment for locally advanced pancreatic cancer
Song YC, Yuan ZY, Li FT, Dong Y, Zhuang HQ, Wang JS, Chen HM, Wang P
OncoTargets and Therapy 2015, 8:1427-1431
Published Date: 12 June 2015
Daily rhythm variations of the clock gene PER1 and cancer-related genes during various stages of carcinogenesis in a golden hamster model of buccal mucosa carcinoma
Ye H, Yang K, Tan XM, Fu XJ, Li HX
OncoTargets and Therapy 2015, 8:1419-1426
Published Date: 11 June 2015
Effect of radiotherapy on survival of women with locally excised ductal carcinoma in situ of the breast: a Surveillance, Epidemiology, and End Results population-based analysis
Qian GW, Ni XJ, Wang Z, Jiang YZ, Yu KD, Shao ZM
OncoTargets and Therapy 2015, 8:1407-1418
Published Date: 10 June 2015
The effect of ataxia-telangiectasia mutated kinase-dependent hyperphosphorylation of checkpoint kinase-2 on oligodeoxynucleotide 7909 containing CpG motifs-enhanced sensitivity to X-rays in human lung adenocarcinoma A549 cells
Liu XQ, Liu XD, Qiao TK, Chen W, Yuan SJ
OncoTargets and Therapy 2015, 8:1399-1406
Published Date: 10 June 2015
Extracellular matrix as target for antitumor therapy
Harisi R, Jeney A
OncoTargets and Therapy 2015, 8:1387-1398
Published Date: 9 June 2015
A comparison of the prognostic value of preoperative inflammation-based scores and TNM stage in patients with gastric cancer
Pan QX, Su ZJ, Zhang JH, Wang CR, Ke SY
OncoTargets and Therapy 2015, 8:1375-1385
Published Date: 16 June 2015
Axitinib versus sorafenib as a second-line therapy in Asian patients with metastatic renal cell carcinoma: results from a randomized registrational study
Qin S, Bi F, Jin J, Cheng Y, Guo J, Ren X, Huang Y, Tarazi J, Tang J, Chen C, Kim S, Ye D
OncoTargets and Therapy 2015, 8:1363-1373
Published Date: 8 June 2015
Decreased pretreatment lymphocyte/monocyte ratio is associated with poor prognosis in stage Ib1–IIa cervical cancer patients who undergo radical surgery
Chen L, Zhang F, Sheng XG, Zhang SQ
OncoTargets and Therapy 2015, 8:1355-1362
Published Date: 8 June 2015
An active treatment of lung adenocarcinoma cancer with brain metastases: icotinib
Zhang Y, Tang HP, Li J, Li M
OncoTargets and Therapy 2015, 8:1351-1354
Published Date: 8 June 2015
Adjuvant treatment in patients at high risk of recurrence of thymoma: efficacy and safety of a three-dimensional conformal radiation therapy regimen
Perri F, Pisconti S, Conson M, Pacelli R, Della Vittoria Scarpati G, Gnoni A, D’Aniello C, Cavaliere C, Licchetta A, Cella L, Giuliano M, Schiavone C, Falivene S, Di Lorenzo G, Buonerba C, Ravo V, Muto P
OncoTargets and Therapy 2015, 8:1345-1349
Published Date: 8 June 2015
Could erlotinib treatment lead to acute cardiovascular events in patients with lung adenocarcinoma after chemotherapy failure?
Kus T, Aktas G, Sevinc A, Kalender ME, Camci C
OncoTargets and Therapy 2015, 8:1341-1343
Published Date: 5 June 2015
Elevated pretreatment plasma D-dimer levels and platelet counts predict poor prognosis in pancreatic adenocarcinoma
Liu P, Zhu Y, Liu L
OncoTargets and Therapy 2015, 8:1335-1340
Published Date: 4 June 2015
The role of Nanog expression in tamoxifen-resistant breast cancer cells
Arif K, Hussain I, Rea C, El-Sheemy M
OncoTargets and Therapy 2015, 8:1327-1334
Published Date: 3 June 2015
Alectinib for choroidal metastasis in a patient with crizotinib-resistant ALK rearranged positive non-small cell lung cancer
Okuma Y, Tanaka Y, Kamei T, Hosomi Y, Okamura T
OncoTargets and Therapy 2015, 8:1321-1325
Published Date: 3 June 2015
Bevacizumab plus cisplatin and helical tomotherapy in treatment of locally advanced nasopharyngeal carcinoma
Li JX, Zhao ZF, Wu X, Yao J, Ma L, Ye R, Niu BL, Liang LQ, Zhao X, Wang QQ
OncoTargets and Therapy 2015, 8:1315-1319
Published Date: 2 June 2015
Computed tomography versus magnetic resonance imaging for diagnosing cervical lymph node metastasis of head and neck cancer: a systematic review and meta-analysis
Sun J, Li B, Li CJ, Li Y, Su F, Gao QH, Wu FL, Yu T, Wu L, Li LJ
OncoTargets and Therapy 2015, 8:1291-1313
Published Date: 8 June 2015
Sudden bilateral hearing loss in gastric cancer as the only symptom of disease
Rakusic Z, Misir Krpan A, Stupin Polancec D, Jakovcevic A, Bisof V
OncoTargets and Therapy 2015, 8:1285-1289
Published Date: 2 June 2015
Clinical utility and patient consideration in the use of lenalidomide for multiple myeloma in Chinese patients
Wang J, Guo H, Zhou X
OncoTargets and Therapy 2015, 8:1277-1284
Published Date: 2 June 2015
Combination of icotinib, surgery, and internal-radiotherapy of a patient with lung cancer severely metastasized to the vertebrae bones with EGFR mutation: a case report
Qu LL, Qin HF, Gao HJ, Liu XQ
OncoTargets and Therapy 2015, 8:1271-1276
Published Date: 2 June 2015
Hyperthermia combined with 5-fluorouracil promoted apoptosis and enhanced thermotolerance in human gastric cancer cell line SGC-7901
Liu T, Ye YW, Zhu AL, Yang Z, Fu Y, Wei CQ, Liu Q, Zhao CL, Wang GJ, Zhang XF
OncoTargets and Therapy 2015, 8:1265-1270
Published Date: 27 May 2015
The clinical significances of the abnormal expressions of Piwil1 and Piwil2 in colonic adenoma and adenocarcinoma
Wang HL, Chen BB, Cao XG, Wang J, Hu, XF, Mu XQ, Chen XB
OncoTargets and Therapy 2015, 8:1259-1264
Published Date: 27 May 2015
Clinical and pathological analysis of 116 cases of adult adrenal cortical adenoma and literature review
Jia AH, Du HQ, Fan MH, Li YH, Xu JL, Niu GF, Bai J, Zhang GZ, Ren YB
OncoTargets and Therapy 2015, 8:1251-1257
Published Date: 28 May 2015
Percutaneous microwave ablation combined with simultaneous transarterial chemoembolization for the treatment of advanced intrahepatic cholangiocarcinoma
Yang GW, Zhao Q, Qian S, Zhu L, Qu XD, Zhang W, Yan ZP, Cheng JM, Liu QX, Liu R, Wang JH
OncoTargets and Therapy 2015, 8:1245-1250
Published Date: 26 May 2015
Value of detection of serum human epididymis secretory protein 4 and carbohydrate antigen 125 in diagnosis of early endometrial cancer of different pathological subtypes
Liu X, Zhao F, Hu L, Sun Y
OncoTargets and Therapy 2015, 8:1239-1243
Published Date: 26 May 2015
Positive feedback between oncogenic KRAS and HIF-1α confers drug resistance in colorectal cancer
Wang Y, Lei F, Rong W, Zeng Q, Sun W
OncoTargets and Therapy 2015, 8:1229-1237
Published Date: 26 May 2015
Clinical analysis of 50 Eastern Asian patients with primary pulmonary large-cell neuroendocrine carcinoma
Zhang XK, Qin T, Zeng YD, Zhao YY, Hou X, Fang WF, Hong SD, Zhou T, Hu ZH, Yang YP, Ma YX, Xue C, Huang Y, Zhao HY, Zhang L
OncoTargets and Therapy 2015, 8:1219-1227
Published Date: 26 May 2015
Antiproliferative effects and molecular mechanisms of troglitazone in human cervical cancer in vitro
Ye J, Yin L, Xie P, Wu J, Huang J, Zhou G, Xu H, Lu E, He X
OncoTargets and Therapy 2015, 8:1211-1218
Published Date: 26 May 2015
Oral treatment with the herbal formula B307 alleviates cardiac toxicity in doxorubicin-treated mice via suppressing oxidative stress, inflammation, and apoptosis
Lien CY, Chuang TY, Hsu CH, Lin CL, Wang SE, Sheu SJ, Chien CT, Wu CH
OncoTargets and Therapy 2015, 8:1193-1210
Published Date: 26 May 2015
HGF and NRG1 protein expression are not poor prognostic markers in surgically resected lung adenocarcinoma
Pan B, Wang R, Huang YL, Garfield D, Zhang J, Chen HQ
OncoTargets and Therapy 2015, 8:1185-1191
Published Date: 25 May 2015
Association of the CYP24A1-rs2296241 polymorphism of the vitamin D catabolism enzyme with hormone-related cancer risk: a meta-analysis
Wang P, Zhang HM, Zhang ZL, Qin LQ, Li BY
OncoTargets and Therapy 2015, 8:1175-1183
Published Date: 22 May 2015
DDMC-p53 gene therapy with or without cisplatin and microwave ablation
Hohenforst-Schmidt W, Zarogoulidis P, Stopek J, Vogl T, Hübner F, Turner JF, Browning R, Zarogoulidis K, Drevelegas A, Drevelegas K, Darwiche K, Freitag L, Rittger H
OncoTargets and Therapy 2015, 8:1165-1173
Published Date: 20 May 2015
The prognostic significance of fibroblast growth factor receptor 4 in non-small-cell lung cancer
Huang H, Feng H, Qiao H, Ren Z, Zhu G
OncoTargets and Therapy 2015, 8:1157-1164
Published Date: 22 May 2015
Tracking the 2015 Gastrointestinal Cancers Symposium: bridging cancer biology to clinical gastrointestinal oncology
Aprile G, Leone F, Giampieri R, Casagrande M, Marino D, Faloppi L, Cascinu S, Fasola G, Scartozzi M
OncoTargets and Therapy 2015, 8:1149-1156
Published Date: 22 May 2015
Anaplastic lymphoma kinase-positive anaplastic large-cell lymphoma with involvement of the urinary bladder: a case report and review of literature
Liang X, Wang Y, Zhang J, Cheng H, Wang J, Dang Y, Li H, Zhou R, Zhang J, Qiao Q
OncoTargets and Therapy 2015, 8:1143-1147
Published Date: 19 May 2015
Combination of afatinib with cetuximab in patients with EGFR-mutant non-small-cell lung cancer resistant to EGFR inhibitors
Ribeiro Gomes J, Cruz MR
OncoTargets and Therapy 2015, 8:1137-1142
Published Date: 19 May 2015
Transforming growth factor-beta-1 is a serum biomarker of radiation-induced pneumonitis in esophageal cancer patients treated with thoracic radiotherapy: preliminary results of a prospective study
Li JX, Mu SF, Mu LX, Zhang XH, Pang RR, Gao SG
OncoTargets and Therapy 2015, 8:1129-1136
Published Date: 19 May 2015
RETRACTED ARTICLE: Knockdown of immature colon carcinoma transcript-1 inhibits proliferation of glioblastoma multiforme cells through Gap 2/mitotic phase arrest
Xie R, Zhang YC, Shen C, Cao XY, Gu SX, Che XM
OncoTargets and Therapy 2015, 8:1119-1127
Published Date: 19 May 2015
Perioperative FOLFOX4 plus bevacizumab for initially unresectable advanced colorectal cancer (NAVIGATE-CRC-01)
Suenaga M, Fujimoto Y, Matsusaka S, Shinozaki E, Akiyoshi T, Nagayama S, Fukunaga Y, Oya M, Ueno M, Mizunuma N, Yamaguchi T
OncoTargets and Therapy 2015, 8:1111-1118
Published Date: 18 May 2015
Radium-223 for the treatment of castration-resistant prostate cancer
El-Amm J, Aragon-Ching JB
OncoTargets and Therapy 2015, 8:1103-1109
Published Date: 18 May 2015
Critical appraisal of the role of ruxolitinib in myeloproliferative neoplasm-associated myelofibrosis
Barosi G, Rosti V, Gale RP
OncoTargets and Therapy 2015, 8:1091-1102
Published Date: 18 May 2015
Comparison of tumor markers using different detection devices
Tao R, Tu SH, Liu C, Yang Q, Zhu M, Shen JF
OncoTargets and Therapy 2015, 8:1083-1090
Published Date: 19 May 2015
Circulating VEGF as a biomarker for diagnosis of ovarian cancer: a systematic review and a meta-analysis
Liang B, He Q, Zhong L, Wang S, Pan Z, Wang T, Zhao Y
OncoTargets and Therapy 2015, 8:1075-1082
Published Date: 15 May 2015
Positive correlation between expression level of mitochondrial serine hydroxymethyltransferase and breast cancer grade
Yin K
OncoTargets and Therapy 2015, 8:1069-1074
Published Date: 14 May 2015
A randomized Phase II clinical study of combining panitumumab and bevacizumab, plus irinotecan, 5-fluorouracil, and leucovorin (FOLFIRI) compared with FOLFIRI alone as second-line treatment for patients with metastatic colorectal cancer and KRAS mutation
Liu YG, Luan LJ, Wang XL
OncoTargets and Therapy 2015, 8:1061-1068
Published Date: 14 May 2015
Primary paraesophageal Ewing’s sarcoma: an uncommon case report and literature review
Tarazona N, Navarro L, Cejalvo JM, Gambardella V, Pérez-Fidalgo JA, Sempere A, Navarro S, Cervantes A
OncoTargets and Therapy 2015, 8:1053-1059
Published Date: 14 May 2015
Tyrphostin AG1296, a platelet-derived growth factor receptor inhibitor, induces apoptosis, and reduces viability and migration of PLX4032-resistant melanoma cells
Li Y, Li Y, Liu Q, Wang A
OncoTargets and Therapy 2015, 8:1043-1051
Published Date: 14 May 2015
Metastatic medullary thyroid cancer: a dramatic response to a systemic chemotherapy (temozolomide and capecitabine) regimen
Lacin S, Esin E, Karakas Y, Yalcin S
OncoTargets and Therapy 2015, 8:1039-1042
Published Date: 13 May 2015
Lung cancer drug therapy in Hungary – 3-year experience
Moldvay J, Rokszin G, Abonyi-Tóth Z, Katona L, Fábián K, Kovács G
OncoTargets and Therapy 2015, 8:1031-1038
Published Date: 11 May 2015
Evaluation of clinical breast examination and breast ultrasonography among pregnant women in Abakaliki, Nigeria
Ezeonu PO, Ajah LO, Onoh RC, Lawani LO, Enemuo VC, Agwu UM
OncoTargets and Therapy 2015, 8:1025-1029
Published Date: 13 May 2015
GCDFP-15, AR, and Her-2 as biomarkers for primary ductal adenocarcinoma of the lacrimal gland: a Chinese case and literature review
Zhu MM, Cui HG, Teng XD
OncoTargets and Therapy 2015, 8:1017-1024
Published Date: 11 May 2015
ABCB1 C3435T polymorphism is associated with leukemia susceptibility: evidence from a meta-analysis
Ma L, Ruan L, Liu H, Yang H, Feng Y
OncoTargets and Therapy 2015, 8:1009-1015
Published Date: 5 May 2015
Personalized treatment strategies for non-small-cell lung cancer in Chinese patients: the role of crizotinib
Niu FY, Wu YL
OncoTargets and Therapy 2015, 8:999-1007
Published Date: 2 May 2015
An analysis of brachytherapy with computed tomography-guided permanent implantation of Iodine-125 seeds for recurrent nonkeratin nasopharyngeal carcinoma
Shen X, Li Y, Zhang Y, Kong J, Li Y
OncoTargets and Therapy 2015, 8:991-997
Published Date: 2 May 2015
Impact of beta-blockers on prostate cancer mortality: a meta-analysis of 16,825 patients
Lu H, Liu XJ, Guo FF, Tan SF, Wang GJ, Liu HJ, Wang JM, He XF, Mo YS, Shi BK
OncoTargets and Therapy 2015, 8:985-990
Published Date: 30 April 2015
SIRT1 expression is associated with poor prognosis of lung adenocarcinoma
Li C, Wang L, Zheng L, Zhan X, Xu B, Jiang J, Wu C
OncoTargets and Therapy 2015, 8:977-984
Published Date: 30 April 2015
GSTM1 null genotype and gastric cancer risk in the Chinese population: an updated meta-analysis and review
Zhang XL, Cui YH
OncoTargets and Therapy 2015, 8:969-975
Published Date: 28 April 2015
Evaluation and comparison of two commercially available targeted next-generation sequencing platforms to assist oncology decision making
Weiss GJ, Hoff BR, Whitehead RP, Sangal A, Gingrich SA, Penny RJ, Mallery DW, Morris SM, Thompson EJ, Loesch DM, Khemka V
OncoTargets and Therapy 2015, 8:959-967
Published Date: 24 April 2015
Severe thrombocytopenia after dasatinib treatment in a patient with Philadelphia chromosome-positive chronic myeloid leukemia
Chen R, Wang F, Zhang X, Gao C, Chen B
OncoTargets and Therapy 2015, 8:955-957
Published Date: 24 April 2015
Effect of blood type on survival of Chinese patients with esophageal squamous cell carcinoma
Qin J, Wu SG, Sun JY, Lin HX, He ZY, Li Q
OncoTargets and Therapy 2015, 8:947-953
Published Date: 23 April 2015
A spectrum of cutaneous toxicities from erlotinib may be a robust clinical marker for non-small-cell lung therapy: a case report and literature review
Jin F, Zhu H, Kong L, Yu JM
OncoTargets and Therapy 2015, 8:943-946
Published Date: 23 April 2015
Randomized Phase II trial of paclitaxel plus valproic acid vs paclitaxel alone as second-line therapy for patients with advanced gastric cancer
Fushida S, Kaji M, Oyama K, Hirono Y, Nezuka H, Takeda T, Tsukada T, Fujimoto D, Ohyama S, Fujimura T, Ohta T
OncoTargets and Therapy 2015, 8:939-941
Published Date: 23 April 2015
Clinical applications of PD-1-based therapy: a focus on pembrolizumab (MK-3475) in the management of melanoma and other tumor types
Gangadhar TC, Salama AK
OncoTargets and Therapy 2015, 8:929-937
Published Date: 22 April 2015
Progression-free survival as a surrogate endpoint for overall survival in patients with third-line or later-line chemotherapy for advanced gastric cancer
Liu L, Yu H, Huang L, Shao F, Bai J, Lou D, Chen F
OncoTargets and Therapy 2015, 8:921-928
Published Date: 22 April 2015
Pilot study investigating the prognostic significance of thymidine phosphorylase expression in patients with metastatic breast cancer: a single institution retrospective analysis
Tedeschi AL, Eslami Z, Garoufalis E, Saleh RR, Omeroglu A, Altinel G, Ait-Tihyaty M, Jean-Claude B, Mihalcioiu C
OncoTargets and Therapy 2015, 8:911-919
Published Date: 21 April 2015
Comparison of uncommon EGFR exon 21 L858R compound mutations with single mutation
Peng L, Song ZG, Jiao SC
OncoTargets and Therapy 2015, 8:905-910
Published Date: 21 April 2015
HES1 is an independent prognostic factor for acute myeloid leukemia
Tian C, Tang Y, Wang T, Yu Y, Wang X, Wang Y, Zhang Y
OncoTargets and Therapy 2015, 8:899-904
Published Date: 22 April 2015
Comparison of single-agent chemotherapy and targeted therapy to first-line treatment in patients aged 80 years and older with advanced non-small-cell lung cancer
Zhang QQ, Wang ZH, Guo J, Liu LY, Han X, Li MM, Fang S, Bi X, Tang N, Liu Y
OncoTargets and Therapy 2015, 8:893-898
Published Date: 20 April 2015
Novel targeted therapies for resistant ALK-rearranged non-small-cell lung cancer: ceritinib and beyond
Kanaan Z, Kloecker GH, Paintal A, Perez CA
OncoTargets and Therapy 2015, 8:885-892
Published Date: 20 April 2015
Synergistic inhibition of colon carcinoma cell growth by Hedgehog-Gli1 inhibitor arsenic trioxide and phosphoinositide 3-kinase inhibitor LY294002
Cai X, Yu K, Zhang L, Li Y, Li Q, Yang Z, Shen T, Duan L, Xiong W, Wang W
OncoTargets and Therapy 2015, 8:877-883
Published Date: 17 April 2015
Enzalutamide for patients with metastatic castration-resistant prostate cancer
Ramadan WH, Kabbara WK, Al Basiouni Al Masri HS
OncoTargets and Therapy 2015, 8:871-876
Published Date: 17 April 2015
Relationship between single-nucleotide polymorphism of matrix metalloproteinase-2 gene and colorectal cancer and gastric cancer susceptibility: a meta-analysis
Wu ZS, Jiang P, Zulqarnain H, Gao H, Zhang WB
OncoTargets and Therapy 2015, 8:861-869
Published Date: 16 April 2015
Outcome of surgical resection for brain metastases and radical treatment of the primary tumor in Chinese non–small-cell lung cancer patients
Li Z, Zhang X, Jiang X, Guo C, Sai K, Yang Q, He Z, Wang Y, Chen Z, Li W, Mou Y
OncoTargets and Therapy 2015, 8:855-860
Published Date: 16 April 2015
Artesunate inhibits the growth and induces apoptosis of human gastric cancer cells by downregulating COX-2
Zhang P, Luo HS, Li M, Tan SY
OncoTargets and Therapy 2015, 8:845-854
Published Date: 16 April 2015
The significance of combining VEGFA, FLT1, and KDR expressions in colon cancer patient prognosis and predicting response to bevacizumab
Zhang SD, McCrudden CM, Meng C, Lin Y, Kwok HF
OncoTargets and Therapy 2015, 8:835-843
Published Date: 15 April 2015
DNA ploidy of cervical epithelial cells should be a cure criterion of high-risk HPV infection in Xinjiang Uygur women
Feng YC, Yang J, Liu CM, Cheng ZZ, Huang YC
OncoTargets and Therapy 2015, 8:827-833
Published Date: 13 April 2015
Profile of nimotuzumab in the treatment of high-grade glioma
Yang Q, Guo C, Chen Z
OncoTargets and Therapy 2015, 8:819-825
Published Date: 13 April 2015
Nimotuzumab enhances radiation sensitivity of NSCLC H292 cells in vitro by blocking epidermal growth factor receptor nuclear translocation and inhibiting radiation-induced DNA damage repair
Teng K, Zhang Y, Hu X, Ding Y, Gong R, Liu L
OncoTargets and Therapy 2015, 8:809-818
Published Date: 13 April 2015
Predictive value of plasma D-dimer levels in patients with advanced non-small-cell lung cancer
Wang Y, Wang Z
OncoTargets and Therapy 2015, 8:805-808
Published Date: 13 April 2015
The combination of preoperative serum C-reactive protein and carcinoembryonic antigen is a useful prognostic factor in patients with esophageal squamous cell carcinoma: a combined ROC analysis
Huang Y, Liu JS, Feng JF
OncoTargets and Therapy 2015, 8:795-803
Published Date: 10 April 2015
Prognostic significance of neutrophil-to-lymphocyte ratio in esophageal cancer: a meta-analysis
Yang X, Huang Y, Feng JF, Liu JS
OncoTargets and Therapy 2015, 8:789-794
Published Date: 10 April 2015
A case of EGFR mutant lung adenocarcinoma that acquired resistance to EGFR-tyrosine kinase inhibitors with MET amplification and epithelial-to-mesenchymal transition
Miyoshi S, Kato T, Katayama H, Ito R, Mizuno Y, Okura T, Higaki J
OncoTargets and Therapy 2015, 8:783-787
Published Date: 9 April 2015
The clinical activity of arsenic trioxide, ascorbic acid, ifosfamide and prednisone combination therapy in patients with relapsed and refractory multiple myeloma
Li X, Sun WJ
OncoTargets and Therapy 2015, 8:775-781
Published Date: 9 April 2015
The effects of PGC-1α on the proliferation and energy metabolism of malignant endometrial cancer cells
Ren Z, Yang H, Wang C, Ma X
OncoTargets and Therapy 2015, 8:769-774
Published Date: 9 April 2015
The human immunodeficiency virus protease inhibitor ritonavir is potentially active against urological malignancies
Sato A
OncoTargets and Therapy 2015, 8:761-768
Published Date: 8 April 2015
GSK1838705A, an insulin-like growth factor-1 receptor/insulin receptor inhibitor, induces apoptosis and reduces viability of docetaxel-resistant prostate cancer cells both in vitro and in vivo
Zhou F, Chen X, Fan S, Tai S, Jiang C, Zhang Y, Hao Z, Zhou J, Shi H, Zhang L, Liang C
OncoTargets and Therapy 2015, 8:753-760
Published Date: 10 April 2015
Gene expression profile analysis of colorectal cancer to investigate potential mechanisms using bioinformatics
Kou YB, Zhang SY, Chen XP, Hu SY
OncoTargets and Therapy 2015, 8:745-752
Published Date: 8 April 2015
Adipose tissue-secreted miR-27a promotes liver cancer by targeting FOXO1 in obese individuals
Sun B, Li J, Shao D, Pan Y, Chen Y, Li S, Yao X, Li H, Liu W, Zhang M, Zhang X, Chen L
OncoTargets and Therapy 2015, 8:735-744
Published Date: 7 April 2015
Association between chemotactic chemokine ligand 5 -403G/A polymorphism and risk of human immunodeficiency virus-1 infection: a meta-analysis
He J, Li X, Tang J, Jin T, Liao Q, Hu G
OncoTargets and Therapy 2015, 8:727-734
Published Date: 7 April 2015
A chromosomal passenger complex protein signature model predicts poor prognosis for non-small-cell lung cancer
Xia R, Chen S, Chen Y, Zhang W, Zhu R, Deng A
OncoTargets and Therapy 2015, 8:721-726
Published Date: 7 April 2015
Development of a preliminary nomogram to predict progression of bone scan for castration-resistant prostate cancer
Lin GW, Ye DW, Jia HX, Dai B, Zhang HL, Zhu Y, Shi GH, Ma CG
OncoTargets and Therapy 2015, 8:713-719
Published Date: 7 April 2015
Apoptosis of HeLa cells induced by a new targeting photosensitizer-based PDT via a mitochondrial pathway and ER stress
Li D, Li L, Li P, Li Y, Chen X
OncoTargets and Therapy 2015, 8:703-711
Published Date: 7 April 2015
Treatment and prognosis of Masaoka stage 3 thymic carcinoma: a retrospective study of 32 cases
Sun Y, Liu J, Yu X
OncoTargets and Therapy 2015, 8:699-702
Published Date: 6 April 2015
BMS-536924, an ATP-competitive IGF-1R/IR inhibitor, decreases viability and migration of temozolomide-resistant glioma cells in vitro and suppresses tumor growth in vivo
Zhou Q
OncoTargets and Therapy 2015, 8:689-697
Published Date: 2 April 2015
The power of the age standardized incidence rate to discover the gene link between cancer diseases: development of a new epidemiological method to save money, time, and effort for genetic scientists
Alghamdi IG, Hussain II, Alghamdi MS, El-Sheemy MA
OncoTargets and Therapy 2015, 8:677-687
Published Date: 31 March 2015
A clinical and radiological objective tumor response with somatostatin analogs (SSA) in well-differentiated neuroendocrine metastatic tumor of the ileum: a case report
De Divitiis C, von Arx C, Carbone R, Tatangelo F, Di Girolamo E, Romano GM, Ottaiano A, de Lutio di Castelguidone E, Iaffaioli RV, Tafuto S
OncoTargets and Therapy 2015, 8:669-675
Published Date: 31 March 2015
Protective effect of gonadotropin-releasing hormone analog on the ovarian reserve in rats receiving cyclophosphamide treatment
Gui T, Yuan GW, Shen K, Cao DY, Yang JX, Wu M, Lang JH
OncoTargets and Therapy 2015, 8:661-667
Published Date: 23 March 2015
Clinical significance of ALDH2 rs671 polymorphism in esophageal cancer: evidence from 31 case-control studies
Zhao TT, Wang C, Shen LL, Gu DY, Xu Z, Zhang XL, Xu Y, Chen JF
OncoTargets and Therapy 2015, 8:649-659
Published Date: 23 March 2015
Association between the ERCC1 rs11615 polymorphism and clinical outcomes of oxaliplatin-based chemotherapies in gastrointestinal cancer: a meta-analysis
Ma SC, Zhao Y, Zhang T, Ling XL, Zhao D
OncoTargets and Therapy 2015, 8:641-648
Published Date: 16 March 2015
Elevated expression of NEDD9 is associated with metastatic activity in gastric cancer
Zhang SS, Wu LH, Liu Q, Chen KS, Zhang XF
OncoTargets and Therapy 2015, 8:633-640
Published Date: 10 March 2015
Early enteral and parenteral nutritional support after hepatectomy in patients with hepatic carcinoma: a systematic review and meta-analysis
Gao LB, Tian H, Wang XG, Yu XF, Guan Y, Chen ML, Zhang J
OncoTargets and Therapy 2015, 8:623-631
Published Date: 10 March 2015
Expression and clinical significance of fibroblast growth factor 1 in gastric adenocarcinoma
Liu NQ, Zhang JG, Sun SX, Yang LG, Zhou ZJ, Sun QL, Niu J
OncoTargets and Therapy 2015, 8:615-621
Published Date: 9 March 2015
The association between the migration inhibitory factor -173G/C polymorphism and cancer risk: a meta-analysis
Zhang X, Weng WH, Xu W, Wang YL, Yu WJ, Tang X, Ma LF, Pan QH, Wang JY, Sun FY
OncoTargets and Therapy 2015, 8:601-613
Published Date: 10 March 2015
Transcatheter arterial chemoembolization with gemcitabine and oxaliplatin for the treatment of advanced biliary tract cancer
Zhao Q, Qian S, Zhu L, Qu XD, Zhang W, Yan ZP, Cheng JM, Liu QX, Liu R, Wang JH
OncoTargets and Therapy 2015, 8:595-600
Published Date: 9 March 2015
Outcomes analysis of an alternative formulation of PEGylated liposomal doxorubicin in recurrent epithelial ovarian carcinoma during the drug shortage era [Corrigendum]
Berger JL, Smith A, Zorn KK, Sukumvanich P, Olawaiye AB, Kelley J, Krivak TC
OncoTargets and Therapy 2015, 8:593-594
Published Date: 9 March 2015
Epoetin beta for the treatment of chemotherapy-induced anemia: an update
Galli L, Ricci C, Egan CG
OncoTargets and Therapy 2015, 8:583-591
Published Date: 5 March 2015
Human papillomavirus 16 infection predicts poor outcome in patients with esophageal squamous cell carcinoma
Xi R, Zhang X, Chen X, Pan S, Hui B, Zhang L, Fu S, Li X, Zhang X, Gong T, Guo J, Che S
OncoTargets and Therapy 2015, 8:573-581
Published Date: 5 March 2015
Single-nucleotide polymorphisms of microRNA processing machinery genes are associated with risk for gastric cancer
Xie Y, Wang Y, Zhao Y, Guo Z
OncoTargets and Therapy 2015, 8:567-571
Published Date: 4 March 2015
Micro-ribonucleic acid 29b inhibits cell proliferation and invasion and enhances cell apoptosis and chemotherapy effects of cisplatin via targeting of DNMT3b and AKT3 in prostate cancer
Yan B, Guo Q, Nan XX, Wang Z, Yin Z, Yi L, Wei YB, Gao YL, Zhou KQ, Yang JR
OncoTargets and Therapy 2015, 8:557-565
Published Date: 4 March 2015
Accumulation of p53 is prognostic for aromatase inhibitor resistance in early-stage postmenopausal patients with ER-positive breast cancer
Jia XQ, Hong Q, Cheng JY, Li JW, Wang YJ, Mo M, Shao ZM, Shen ZZ, Liu GY
OncoTargets and Therapy 2015, 8:549-555
Published Date: 3 March 2015
The role of miR-29b in cancer: regulation, function, and signaling
Yan B, Guo Q, Fu FJ, Wang Z, Yin Z, Wei YB, Yang JR
OncoTargets and Therapy 2015, 8:539-548
Published Date: 3 March 2015
Comparison between three oxaliplatin-based regimens with bevacizumab in patients with metastatic colorectal cancer
Ohhara Y, Suenaga M, Matsusaka S, Shinozaki E, Mizunuma N, Yamaguchi T
OncoTargets and Therapy 2015, 8:529-537
Published Date: 3 March 2015
An update on PARP inhibitors for the treatment of cancer
Benafif S, Hall M
OncoTargets and Therapy 2015, 8:519-528
Published Date: 26 February 2015
Nimotuzumab abrogates acquired radioresistance of KYSE-150R esophageal cancer cells by inhibiting EGFR signaling and cellular DNA repair
Liu H, Yang W, Gao H, Jiang T, Gu B, Dong Q, Xu W, Wu S, Sun X
OncoTargets and Therapy 2015, 8:509-518
Published Date: 25 February 2015
Cell death in response to antimetabolites directed at ribonucleotide reductase and thymidylate synthase
Asuncion Valenzuela MM, Castro I, Gonda A, Diaz Osterman CJ, Jutzy JM, Aspe JR, Khan S, Neidigh JW, Wall NR
OncoTargets and Therapy 2015, 8:495-507
Published Date: 26 February 2015
Validation of the Memorial Sloan Kettering Cancer Center nomogram for predicting non-sentinel lymph node metastasis in sentinel lymph node-positive breast-cancer patients
Bi X, Wang Y, Li M, Chen P, Zhou Z, Liu Y, Zhao T, Zhang Z, Wang C, Sun X, Qiu P
OncoTargets and Therapy 2015, 8:487-493
Published Date: 23 February 2015
Assessment of selected cytokines, proteins, and growth factors in the peritoneal fluid of patients with ovarian cancer and benign gynecological conditions
Chudecka-Głaz AM, Cymbaluk-Płoska AA, Menkiszak JL, Pius-Sadowska E, Machaliński BB, Sompolska-Rzechuła A, Rzepka-Górska IA
OncoTargets and Therapy 2015, 8:471-485
Published Date: 23 February 2015
Epigallocatechin-3-gallate suppresses cell proliferation and promotes apoptosis and autophagy in oral cancer SSC-4 cells
Irimie AI, Braicu C, Zanoaga O, Pileczki V, Gherman C, Berindan-Neagoe I, Campian RS
OncoTargets and Therapy 2015, 8:461-470
Published Date: 20 February 2015
Astroblastoma: beside being a tumor entity, an occasional phenotype of astrocytic gliomas?
Mellai M, Piazzi A, Casalone C, Grifoni S, Melcarne A, Annovazzi L, Cassoni P, Denysenko T, Valentini MC, Cistaro A, Schiffer D
OncoTargets and Therapy 2015, 8:451-460
Published Date: 19 February 2015
The imaging features of metanephric adenoma: a case report and review of literature
Hu YC, Wu L, Yan LF, Zhang W, Cui GB
OncoTargets and Therapy 2015, 8:445-449
Published Date: 13 February 2015
Multimodality therapy is recommended for limited-stage combined small cell esophageal carcinoma
Wang HH, Zaorsky NG, Meng MB, Wu ZQ, Zeng XL, Jiang B, Jiang C, Zhao LJ, Yuan ZY, Wang P
OncoTargets and Therapy 2015, 8:437-444
Published Date: 13 February 2015
Andrographolide inhibits hypoxia-inducible factor-1 through phosphatidylinositol 3-kinase/AKT pathway and suppresses breast cancer growth
Li J, Zhang C, Jiang H, Cheng J
OncoTargets and Therapy 2015, 8:427-435
Published Date: 13 February 2015
Single-nucleotide polymorphisms of microRNA processing machinery genes and risk of colorectal cancer
Zhao Y, Du Y, Zhao S, Guo Z
OncoTargets and Therapy 2015, 8:421-425
Published Date: 12 February 2015
High mobility group box-1 and its clinical value in breast cancer
Sun S, Zhang W, Cui Z, Chen Q, Xie P, Zhou C, Liu B, Peng X, Zhang Y
OncoTargets and Therapy 2015, 8:413-419
Published Date: 12 February 2015
Prophylaxis and treatment of acute lymphoblastic leukemia relapse after allogeneic hematopoietic stem cell transplantation
Chen R, Campbell JL, Chen B
OncoTargets and Therapy 2015, 8:405-412
Published Date: 10 February 2015
Use of allogeneic platelet gel in the management of chemotherapy extravasation injuries: a case report
Di Costanzo G, Loquercio G, Marcacci G, Iervolino V, Mori S, Petruzziello A, Barra P, Cacciapuoti C
OncoTargets and Therapy 2015, 8:401-404
Published Date: 9 February 2015
The clue of a possible etiology about spontaneous regression of hepatocellular carcinoma: a perspective on pathology
Wang Z, Ke ZF, Lu XF, Luo CJ, Liu YD, Lin ZW, Wang LT
OncoTargets and Therapy 2015, 8:395-400
Published Date: 5 February 2015
XPA A23G polymorphism and risk of digestive system cancers: a meta-analysis
He L, Deng T, Luo H
OncoTargets and Therapy 2015, 8:385-394
Published Date: 5 February 2015
Novel covalent modification of human anaplastic lymphoma kinase (ALK) and potentiation of crizotinib-mediated inhibition of ALK activity by BNP7787
Parker AR, Petluru PN, Nienaber VL, Zhao M, Ayala PY, Badger J, Chie-Leon B, Sridhar V, Logan C, Kochat H, Hausheer FH
OncoTargets and Therapy 2015, 8:375-383
Published Date: 4 February 2015
The utility of bexarotene in mycosis fungoides and Sézary syndrome
Panchal MR, Scarisbrick JJ
OncoTargets and Therapy 2015, 8:367-373
Published Date: 3 February 2015
Disruption of human papillomavirus 16 E6 gene by clustered regularly interspaced short palindromic repeat/Cas system in human cervical cancer cells [Corrigendum]
Yu L, Wang XL, Zhu D, Ding WC, Wang LM, Zhang CL, Jiang XH, Shen H, Liao SJ, Ma D, Hu Z, Wang H
OncoTargets and Therapy 2015, 8:365-366
Published Date: 4 February 2015
MicroRNA-153 acts as a prognostic marker in gastric cancer and its role in cell migration and invasion
Zhang Z, Sun J, Bai Z, Li H, He S, Chen R, Che X
OncoTargets and Therapy 2015, 8:357-364
Published Date: 2 February 2015
Use of transient elastography to predict de novo recurrence after radiofrequency ablation for hepatocellular carcinoma
Lee SH, Kim SU, Jang JW, Bae SH, Lee SH, Kim BK, Park JY, Kim DY, Ahn SH, Han KH
OncoTargets and Therapy 2015, 8:347-356
Published Date: 2 February 2015
Cytotoxic effect of lapatinib is restricted to human papillomavirus-positive head and neck squamous cell carcinoma cell lines
Fumagalli I, Dugue D, Bibault JE, Clémenson C, Vozenin MC, Mondini M, Deutsch E
OncoTargets and Therapy 2015, 8:335-345
Published Date: 2 February 2015
Targeting specificity of dendritic cells on breast cancer stem cells: in vitro and in vivo evaluations
Nguyen ST, Nguyen HL, Pham VQ, Nguyen GT, Tran CD, Phan NK, Pham PV
OncoTargets and Therapy 2015, 8:323-334
Published Date: 30 January 2015
Targeted therapies for renal cell carcinoma in Chinese patients: focus on everolimus
Tan X, Liu Y, Hou J, Cao G
OncoTargets and Therapy 2015, 8:313-321
Published Date: 29 January 2015
Tubeimoside-1 induces glioma apoptosis through regulation of Bax/Bcl-2 and the ROS/Cytochrome C/Caspase-3 pathway
Jia G, Wang Q, Wang R, Deng D, Xue L, Shao N, Zhang Y, Xia X, Zhi F, Yang Y
OncoTargets and Therapy 2015, 8:303-311
Published Date: 30 January 2015
In vivo DNA damaging and apoptotic potential of silver nanoparticles in Swiss albino mice
Al Gurabi MA, Ali D, Alkahtani S, Alarifi S
OncoTargets and Therapy 2015, 8:295-302
Published Date: 29 January 2015
Efficacy of nab-paclitaxel plus trastuzumab in a long-surviving heavily pretreated HER2-positive breast cancer patient with brain metastases
Ricciardi GRR, Russo A, Franchina T, Ferraro G, Adamo V
OncoTargets and Therapy 2015, 8:289-294
Published Date: 2 February 2015
The impact of IGF-1R expression on the outcomes of patients with breast cancer: a meta-analysis
Yan S, Jiao X, Li K, Li W, Zou H
OncoTargets and Therapy 2015, 8:279-287
Published Date: 29 January 2015
NVP-BEZ235 overcomes gefitinib-acquired resistance by down-regulating PI3K/AKT/ mTOR phosphorylation
Sun ZH, Li QH, Zhang S, Chen J, Huang LL, Ren JH, Chang Y, Liang YC, Wu G
OncoTargets and Therapy 2015, 8:269-277
Published Date: 29 January 2015
Primary malignant lymphoma of the uterus and broad ligament: a case report and review of literature
Chen R, Yu Z, Zhang H, Ding J, Chen B
OncoTargets and Therapy 2015, 8:265-268
Published Date: 29 January 2015
Changes in sebum levels and the development of acneiform rash in patients with non–small cell lung cancer after treatment with EGFR inhibitors
Nakahara T, Moroi Y, Takayama K, Itoh E, Kido-Nakahara M, Nakanishi Y, Furue M
OncoTargets and Therapy 2015, 8:259-263
Published Date: 28 January 2015
Prolonged radiation time and low nadir hemoglobin during postoperative concurrent chemoradiotherapy are both poor prognostic factors with synergistic effect on locally advanced head and neck cancer patients
Su NW, Liu CJ, Leu YS, Lee JC, Chen YJ, Chang YF
OncoTargets and Therapy 2015, 8:251-258
Published Date: 28 January 2015
Anticoagulant therapy for venous thromboembolism detected by Doppler ultrasound in patients with metastatic colorectal cancer receiving bevacizumab
Suenaga M, Mizunuma N, Shinozaki E, Matsusaka S, Ozaka M, Ogura M, Chin K, Yamaguchi T
OncoTargets and Therapy 2015, 8:243-249
Published Date: 27 January 2015
Using an innovative multiple regression procedure in a cancer population (Part I): detecting and probing relationships of common interacting symptoms (pain, fatigue/weakness, sleep problems) as a strategy to discover influential symptom pairs and clusters [Erratum]
Francoeur RB
OncoTargets and Therapy 2015, 8:241-242
Published Date: 23 January 2015
Tumor deposit is a poor prognostic indicator in patients who underwent simultaneous resection for synchronous colorectal liver metastases
Lin Q, Wei Y, Ren L, Zhong Y, Qin C, Zheng P, Xu P, Zhu D, Ji M, Xu J
OncoTargets and Therapy 2015, 8:233-240
Published Date: 22 January 2015
Impact on growth and invasion of gastric cancer cell lines by silencing NEDD9
Zhang SS, Wu LH, Liu Q, Chen KS, Zhang XF
OncoTargets and Therapy 2015, 8:223-231
Published Date: 20 January 2015
Meta-analysis of the association between APC promoter methylation and colorectal cancer
Ding ZY, Jiang T, Piao Y, Han T, Han YL, Xie XD
OncoTargets and Therapy 2015, 8:211-222
Published Date: 19 January 2015
Oncogenic mutation profiling in new lung cancer and mesothelioma cell lines
Lam DC, Luo SY, Deng W, Kwan JS, Rodriguez-Canales J, Cheung AL, Cheng GH, Lin CH, Wistuba II, Sham PC, Wan TS, Tsao SW
OncoTargets and Therapy 2015, 8:195-209
Published Date: 16 January 2015
Triple-negative breast cancer: new perspectives for targeted therapies
Tomao F, Papa A, Zaccarelli E, Rossi L, Caruso D, Minozzi M, Vici P, Frati L, Tomao S
OncoTargets and Therapy 2015, 8:177-193
Published Date: 16 January 2015
HMGA2 is associated with epithelial–mesenchymal transition and can predict poor prognosis in nasopharyngeal carcinoma
Xia YY, Yin L, Tian H, Guo WJ, Jiang N, Jiang XS, Wu J, Chen M, Wu JZ, He X
OncoTargets and Therapy 2015, 8:169-176
Published Date: 17 January 2015
BRAF-mutant melanoma: treatment approaches, resistance mechanisms, and diagnostic strategies
Spagnolo F, Ghiorzo P, Orgiano L, Pastorino L, Picasso V, Tornari E, Ottaviano V, Queirolo P
OncoTargets and Therapy 2015, 8:157-168
Published Date: 16 January 2015
Prognostic role of apoptosis-related gene functional variants in advanced non-small-cell lung cancer patients treated with first-line platinum-based chemotherapy
Tao KY, Li XX, Xu WZ, Wang Y, Zhu SM, Xie HX, Luo WH, Xu YJ, Xu XL
OncoTargets and Therapy 2015, 8:147-155
Published Date: 14 January 2015
Low preoperative lymphocyte to monocyte ratio predicts poor cancer-specific survival in patients with esophageal squamous cell carcinoma
Huang Y, Feng JF
OncoTargets and Therapy 2015, 8:137-145
Published Date: 8 January 2015
Advances in the targeted therapy of liposarcoma
Guan Z, Yu X, Wang H, Wang H, Zhang J, Li G, Cao J, Teng L
OncoTargets and Therapy 2015, 8:125-136
Published Date: 5 January 2015
Clinical and epidemiological study of EGFR mutations and EML4-ALK fusion genes among Indian patients with adenocarcinoma of the lung
Doval DC, Prabhash K, Patil S, Chaturvedi H, Goswami C, Vaid AK, Desai S, Dutt S, Veldore VH, Jambhekar N, Mehta A, Hazarika D, Azam S, Gawande S, Gupta S
OncoTargets and Therapy 2015, 8:117-123
Published Date: 5 January 2015
Lung cancer patients harboring epidermal growth factor receptor mutation among those infected by human immunodeficiency virus
Okuma Y, Hosomi Y, Imamura A
OncoTargets and Therapy 2015, 8:111-115
Published Date: 31 December 2014
Ethanol extracts of Cinnamomum kanehirai Hayata leaves induce apoptosis in human hepatoma cell through caspase-3 cascade
Liu YK, Chen KH, Leu YL, Way TD, Wang LW, Chen YJ, Liu YM
OncoTargets and Therapy 2015, 8:99-109
Published Date: 31 December 2014
Breast metastases of gastric signet-ring cell carcinoma: a report of two cases and review of the literature
Iesato A, Oba T, Ono M, Hanamura T, Watanabe T, Ito T, Kanai T, Maeno K, Ishizaka K, Kitabatake H, Takeuchi D, Suzuki A, Nakayama J, Ito K
OncoTargets and Therapy 2015, 8:91-97
Published Date: 29 December 2014
Decreased expression of APAF-1 and increased expression of cathepsin B in invasive pituitary adenoma
Tanase C, Albulescu R, Codrici E, Calenic B, Popescu ID, Mihai S, Necula L, Cruceru ML, Hinescu ME
OncoTargets and Therapy 2015, 8:81-90
Published Date: 22 December 2014
The landscape of alternative splicing in cervical squamous cell carcinoma
Guo P, Wang D, Wu J, Yang J, Ren T, Zhu B, Xiang Y
OncoTargets and Therapy 2015, 8:73-79
Published Date: 22 December 2014
Using an innovative multiple regression procedure in a cancer population (Part II): fever, depressive affect, and mobility problems clarify an influential symptom pair (pain–fatigue/weakness) and cluster (pain–fatigue/weakness–sleep problems)
Francoeur RB
OncoTargets and Therapy 2015, 8:57-72
Published Date: 22 December 2014
Using an innovative multiple regression procedure in a cancer population (Part I): detecting and probing relationships of common interacting symptoms (pain, fatigue/weakness, sleep problems) as a strategy to discover influential symptom pairs and clusters
Francoeur RB
OncoTargets and Therapy 2015, 8:45-56
Published Date: 22 December 2014
Disruption of human papillomavirus 16 E6 gene by clustered regularly interspaced short palindromic repeat/Cas system in human cervical cancer cells
Yu L, Wang XL, Zhu D, Ding WC, Wang LM, Zhang CL, Jiang XH, Shen H, Liao SJ, Ma D, Hu Z, Wang H
OncoTargets and Therapy 2015, 8:37-44
Published Date: 22 December 2014
Fertility sparing surgery in young women affected by endometrial stromal sarcoma: an oncologic dilemma or a reliable option? review of literature starting from a peculiar case
Noventa M, Gizzo S, Conte L, Dalla Toffola A, Litta P, Saccardi C
OncoTargets and Therapy 2015, 8:29-35
Published Date: 18 December 2014
Lumbosacral plexus delineation, dose distribution, and its correlation with radiation-induced lumbosacral plexopathy in cervical cancer patients
Tunio M, Al Asiri M, Bayoumi Y, Abdullah O Balbaid A, AlHameed M, Gabriela SL, Amir O Ali A
OncoTargets and Therapy 2015, 8:21-27
Published Date: 23 December 2014
Neoadjuvant hormone therapy following treatment with robotic-assisted radical prostatectomy achieved favorable in high-risk prostate cancer
Hou CP, Lee WC, Lin YH, Chen SM, Chen CL, Chang PL, Juang HH, Tsui KH
OncoTargets and Therapy 2015, 8:15-19
Published Date: 17 December 2014
Assessment and prognostic analysis of EGFR, HER2, and HER3 protein expression in surgically resected gastric adenocarcinomas
Tang D, Liu YJ, Shen D, Fan S, Su X, Ye P, Gavine PR, Yin X
OncoTargets and Therapy 2015, 8:7-14
Published Date: 16 December 2014
Efficacy of sorafenib in advanced differentiated and medullary thyroid cancer: experience in a Turkish population
Benekli M, Yalcin S, Ozkan M, Elkiran ET, Sevinc A, Cabuk D, Coskun HS, Oksuzoglu B, Bayar B, Akbulat A, Ozet A
OncoTargets and Therapy 2015, 8:1-5
Published Date: 15 December 2014